Edgewell Personal Care (EPC) 10-Q6 Aug 192019 Q3 Quarterly reportFinancial data

Company Profile

Document

Document - shares	9 Months Ended
Document - shares	Jun. 30, 2019	Jul. 31, 2019
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2019
Document Transition Report	false
Entity File Number	001-15401
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Incorporation, State or Country Code	MO
Entity Tax Identification Number	43-1863181
Entity Address, Address Line One	6 Research Drive
Entity Address, City or Town	Shelton,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06484
City Area Code	(203)
Local Phone Number	944-5500
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	EPC
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		54,160,966
Entity Central Index Key	0001096752
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Amendment Flag	false

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Net sales	$ 609.2	$ 620.6	$ 1,613	$ 1,697
Cost of products sold	317	318.9	876.4	894.9
Gross profit	292.2	301.7	736.6	802.1
Selling, general and administrative expense	94.8	101.3	280.2	303.5
Advertising and sales promotion expense	91.8	105.3	191.3	229.9
Research and development expense	12.9	14.9	39.5	46.5
Impairment charges	549	24.4	549	24.4
Restructuring charges	7.1	15.4	37.7	19.1
Sale of Playtex gloves	0	0.6	0	(15.3)
Interest expense associated with debt	15.6	16.5	48	52.5
Other expense, net	2.7	1.9	1.3	1.2
(Loss) earnings before income taxes	(481.7)	21.4	(410.4)	140.3
Income tax (benefit) provision	(40.3)	9.3	(16.8)	56.4
Net (loss) earnings	$ (441.4)	$ 12.1	$ (393.6)	$ 83.9
Basic net (loss) earnings per share	$ (8.16)	$ 0.23	$ (7.27)	$ 1.54
Diluted net (loss) earnings per share	$ (8.16)	$ 0.22	$ (7.27)	$ 1.54
Condensed Consolidated Statements of Comprehensive Income
Net (loss) earnings	$ (441.4)	$ 12.1	$ (393.6)	$ 83.9
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	12.6	(36.3)	(9.4)	(10.4)
Pension and postretirement activity, net of tax	(0.5)	1.9	(0.2)	2.6
Deferred (loss) gain on hedging activity, net of tax	(2)	4.4	(3)	2.9
Total other comprehensive income (loss), net of tax	10.1	(30)	(12.6)	(4.9)
Total comprehensive (loss) income	$ (431.3)	$ (17.9)	$ (406.2)	$ 79

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Pension and postretirement activity, tax	$ (0.2)	$ 0.9	$ 0.1	$ 1.1
Deferred (loss) gain on hedging activity, tax	$ (0.9)	$ (2)	$ (1.4)	$ (1.3)

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2019	Sep. 30, 2018
Current assets
Cash and cash equivalents	$ 279	$ 266.4
Trade receivables, less allowance for doubtful accounts	241.6	226.5
Inventories	372.7	329.5
Other current assets	142.3	128.8
Total current assets	1,035.6	951.2
Property, plant and equipment, net	400.7	424.1
Goodwill	1,060.2	1,450.8
Other intangible assets, net	921.4	1,099
Other assets	34.4	28.2
Total assets	3,452.3	3,953.3
Current liabilities
Current maturities of long-term debt	125	184.9
Notes payable	12.6	8.2
Accounts payable	221.9	238.4
Other current liabilities	319.1	285.5
Total current liabilities	678.6	717
Long-term debt	1,097.5	1,103.8
Deferred income tax liabilities	118.7	176.1
Other liabilities	203	211.8
Total liabilities	2,097.8	2,208.7
Shareholders’ equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,632.8	1,628.3
Retained earnings	693.4	1,083.1
Common shares in treasury at cost	(811.5)	(819.2)
Accumulated other comprehensive loss	(160.9)	(148.3)
Total shareholders’ equity	1,354.5	1,744.6
Total liabilities and shareholders’ equity	$ 3,452.3	$ 3,953.3

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2019	Sep. 30, 2018
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5.7	$ 6
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	54,129,125	54,040,386
Treasury shares (in shares)	11,122,864	11,211,603

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash Flow from Operating Activities
Net (loss) earnings	$ (393.6)	$ 83.9
Impairment charges	549	24.4
Depreciation and amortization	69.2	73.4
Share-based compensation expense	13.8	14
Loss (gain) on sale of assets	1.4	(13)
Deferred compensation payments	(7.3)	(15.4)
Deferred income taxes	(56.8)	(22.9)
Other, net	(0.3)	32
Changes in operating assets and liabilities	(77.2)	5.1
Net cash from operating activities	98.2	181.5
Cash Flow from Investing Activities
Capital expenditures	(38.7)	(41.8)
Acquisitions, net of cash acquired	0	(90.2)
Playtex gloves sale	0	19
Proceeds from sale of assets	4.1	4.7
Collection of deferred purchase price on accounts receivable sold	9	7.2
Payments for other investing activities	(1.3)	0
Net cash used by investing activities	(26.9)	(101.1)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	316	477
Cash payments on debt with original maturities greater than 90 days	(198)	(722)
Term Loan repayment	185	0
Net increase in debt with original maturities of 90 days or less	5.7	0.2
Common shares purchased	0	(124.4)
Net financing inflow from the Accounts Receivable Facility	5.6	4.6
Employee shares withheld for taxes	(1.8)	(2.2)
Net cash used by financing activities	(57.5)	(366.8)
Effect of exchange rate changes on cash	(1.2)	2
Cash and cash equivalents, beginning of period	266.4	502.9
Cash and cash equivalents, end of period	$ 279	$ 218.5

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Changes in Shareholders' Equity Statement - USD ($) $ in Millions	Total	Common shares	Treasury shares	Additional paid-in capital	Retained earnings	Accumulated other comprehensive loss
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)			(9,200,000)
Total shareholders' equity at Sep. 30, 2017	$ 1,741.7	$ 0.7	$ (703.9)	$ 1,623.4	$ 952.9	$ (131.4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	83.9				83.9
Foreign currency translation adjustments	(10.4)					(10.4)
Pension and postretirement activity, net of tax	2.6					2.6
Deferred (loss) gain on hedging activity, net of tax	2.9					2.9
Activity under share plans (in shares)			100,000
Activity under share plans (in usd)	21.6		$ 5.9	6	9.7
Repurchase of shares (in shares)			(2,100,000)
Repurchase of shares (in usd)	(124.4)		$ (124.4)
Total shareholders' equity at Jun. 30, 2018	1,717.9	$ 0.7	$ (822.4)	1,629.4	1,046.5	(136.3)
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)			(11,200,000)
Total shareholders' equity at Mar. 31, 2018	1,731.3	$ 0.7	$ (822.7)	1,625.2	1,034.4	(106.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	12.1				12.1
Foreign currency translation adjustments	(36.3)					(36.3)
Pension and postretirement activity, net of tax	1.9					1.9
Deferred (loss) gain on hedging activity, net of tax	4.4					4.4
Activity under share plans (in shares)			0
Activity under share plans (in usd)	4.5		$ 0.3	4.2	0
Repurchase of shares (in shares)			0
Repurchase of shares (in usd)	0		$ 0
Total shareholders' equity at Jun. 30, 2018	$ 1,717.9	$ 0.7	$ (822.4)	1,629.4	1,046.5	(136.3)
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)			(11,200,000)
Common shares, issued (in shares)	65,251,989	65,200,000
Treasury shares (in shares)	11,211,603		(11,200,000)
Total shareholders' equity at Sep. 30, 2018	$ 1,744.6	$ 0.7	$ (819.2)	1,628.3	1,083.1	(148.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	(393.6)				(393.6)
Foreign currency translation adjustments	(9.4)					(9.4)
Pension and postretirement activity, net of tax	(0.2)					(0.2)
Deferred (loss) gain on hedging activity, net of tax	(3)					(3)
Activity under share plans (in shares)			100,000
Activity under share plans (in usd)	12.2		$ 7.7	4.5	0
Total shareholders' equity at Jun. 30, 2019	1,354.5	$ 0.7	$ (811.5)	1,632.8	693.4	(160.9)
Common shares, issued (in shares)		65,200,000
Treasury shares (in shares)			(11,100,000)
Total shareholders' equity at Mar. 31, 2019	1,782.1	$ 0.7	$ (812.4)	1,630	1,134.8	(171)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) earnings	(441.4)				(441.4)
Foreign currency translation adjustments	12.6					12.6
Pension and postretirement activity, net of tax	(0.5)					(0.5)
Deferred (loss) gain on hedging activity, net of tax	(2)					(2)
Activity under share plans (in shares)			0
Activity under share plans (in usd)	3.7		$ 0.9	2.8	0
Total shareholders' equity at Jun. 30, 2019	$ 1,354.5	$ 0.7	$ (811.5)	$ 1,632.8	693.4	$ (160.9)
Common shares, issued (in shares)	65,251,989	65,200,000
Treasury shares (in shares)	11,122,864		(11,100,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Impact of adoption of new accounting pronouncements \| Accounting standards update 2016-06	$ 3.9				$ 3.9

Background and Basis of Present

Background and Basis of Presentation	9 Months Ended
Background and Basis of Presentation	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company, and its subsidiaries (collectively, “Edgewell” or the “Company”), is one of the world’s largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care, and infant care categories. Edgewell has a portfolio of over 25 brands and a global footprint in more than 50 countries. The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard® and Personna® brands, as well as non-branded products. The Company’s wet shave products include razor handles and refillable blades, disposable shave products, and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products, Jack Black® and Bulldog® men’s skin care products, Wet Ones® wipes, and, until its sale in October 2017, the Playtex® household gloves business. • Feminine Care includes tampons, pads, and liners sold under the Playtex Gentle Glide® and Sport®, Stayfree®, Carefree®, and o.b.® brands. • All Other includes infant care products, such as bottles, cups, and pacifiers, sold under the Playtex, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”), under the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s Audited Annual Consolidated Financial Statements included in its Annual Report on Form 10-K filed with the SEC on November 19, 2018 (“2018 Annual Report”). Statement of Cash Flows Presentation. Certain amounts within Cash Flows from Operating Activities for the nine months ended June 30, 2018 have been reclassified to conform with the current period presentation. Net cash from operating activities for the nine months ended June 30, 2018 was not impacted by this change. Recently Adopted Accounting Pronouncements. In May 2014, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) which provides a single comprehensive revenue recognition model for all contracts with customers to improve comparability within industries, across industries, and across capital markets. During 2016, the FASB issued three ASUs clarifying the revenue recognition implementation guidance on various topics included within the original ASU. The Company adopted the ASU for revenue recognition beginning October 1, 2018 using the modified retrospective method. Revenues are primarily generated from the sale of finished products to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when the performance obligations within the contract have been completed. As a result, the adoption of the ASU did not have a material impact on the timing of revenue recognition. The adoption resulted in the recognition of a $5.3 inventory return asset included in Other current assets on the Condensed Consolidated Balance Sheet as of October 1, 2018 with an offsetting increase to the returns reserve in Other current liabilities. The adoption resulted in the recognition of a $1.3 liability for advanced payments from customers in Other current liabilities with a corresponding increase to Trade receivables to reclassify advanced payments from customers from contra-Trade receivables as of October 1, 2018. Refer to Note 2 in the Notes to the Condensed Consolidated Financial Statements for further discussion. In August 2016, the FASB issued an ASU intended to address diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The amendments provide guidance on specific cash flow issues, including debt prepayment or debt extinguishment costs, the sale of accounts receivable, contingent consideration payments on business combinations, proceeds from the settlement of insurance claims, and distributions received from equity method investees, among others. The Company adopted the ASU beginning October 1, 2018. The Company noted that the adoption of the ASU resulted in the reclassification of approximately $9.0 and $7.2 in operating cash inflows for the nine months ended June 30, 2019 and 2018, respectively, associated with the $150 uncommitted master accounts receivable purchase agreement entered into on September 15, 2017 with The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch, as the purchaser (the “Accounts Receivable Facility”) to investing cash inflows in the Consolidated Statement of Cash Flows. In October 2016, the FASB issued ASU 2016-16 intended to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Under the new guidance, an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory, such as intellectual property and property, plant, and equipment, when the transfer occurs. The Company adopted the standard beginning October 1, 2018. The impact of the adoption of the ASU resulted in the recognition of a deferred tax asset and a credit to retained earnings of $3.9 . In January 2017, the FASB issued an ASU clarifying the definition of a business, reducing the number of transactions that need to be further evaluated, and providing a framework to assist entities in evaluating whether both an input and a substantive process are present. The amendments set forth in the ASU specify that when the fair value of the gross assets acquired or disposed of is concentrated in a single identifiable asset or a group of similarly identifiable assets, the integrated set of assets and activities is not a business. The guidance also requires that an integrated set of assets and activities must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output to be considered a business and removes the evaluation of whether a market participant could replace the missing elements. The Company adopted the ASU beginning October 1, 2018. The impact of the ASU will be dependent upon the nature of any future acquisitions or dispositions made by the Company. In March 2017, the FASB issued an ASU intended to improve the presentation of net periodic pension and post-retirement benefit cost. The amendment changes these requirements so that only the service cost component is recorded in the same line item as other compensation costs for the applicable employees, and all other components of net periodic pension and post-retirement benefit cost are recorded on a separate line item outside of income from operations. The amendments also specify that only the service cost component is eligible for capitalization. The Company adopted the ASU as of October 1, 2018, applied the ASU retrospectively for the presentation of the cost components, and applied the ASU prospectively for the capitalization of the service cost component. The adoption impacted the Consolidated Statement of Operations for the quarter ended June 30, 2018 and resulted in a reclassification that increased Cost of products sold, Selling, general and administrative expense (“SG&A”), and decreased Other expense, net by $1.0 , $0.6 , and $1.6 , respectively. The adoption impacted the Consolidated Statement of Operations for the nine months ended June 30, 2018 and resulted in a reclassification that increased Cost of products sold, SG&A, and decreased Other expense, net by $3.0 , $2.1 , and $5.1 , respectively. In May 2017, the FASB issued an ASU that clarifies the scope of accounting for modifications of share-based payment awards. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The Company adopted the ASU beginning October 1, 2018 and noted that the impact on its financial statements was not material. Recently Issued Accounting Pronouncements. In February 2016, the FASB issued an ASU which amends existing lease accounting guidance to require recognition of lease assets and lease liabilities on the balance sheet for leases previously classified as operating leases. Additionally, this update requires qualitative disclosure along with specific quantitative disclosures. Lessees and lessors will be required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach. The update will be effective for the Company beginning October 1, 2019, with early adoption permitted. The Company has begun assessing the impact of the standard, identified the components of the lease portfolio, and begun implementing business process changes and controls including new lease accounting software required to correctly apply the guidance across the organization. The Company will adopt this guidance October 1, 2019 with no restatement of prior period amounts. The Company is in the process of evaluating its impact on the financial statements; however, the Company anticipates the primary impacts will be a material increase in both assets and liabilities to include operating leases on the Consolidated Balance Sheet. No other new accounting pronouncement issued or effective during fiscal 2019 which was not previously disclosed in the 2018 Annual Report had or is expected to have a material impact on our consolidated financial statements or related disclosures.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	9 Months Ended
Revenue from Contracts with Customers	Jun. 30, 2019
Revenue from Contract with Customer [Abstract]
Revenue from contracts with customers	Revenue Recognition On October 1, 2018, the Company adopted ASU 2014-09 which provided guidance for accounting for revenue from contracts with customers. The Company adopted the standard beginning October 1, 2018 using the modified retrospective method and applied the standard to contracts not completed at the adoption date. No adjustment to retained earnings was required on October 1, 2018. The adoption resulted in changes to how the Company reflects returns and advanced payments received from customers on the Consolidated Balance Sheet. Results for periods ending after October 1, 2018 are recognized and presented in accordance with the new standard, while prior period amounts have not been adjusted and continue to be reported in accordance with the prior accounting guidance. Other impacts related to the adoption of the standard were not material to the Consolidated Financial Statements. Refer to Note 15 in the Notes to the Condensed Consolidated Financial Statements for the Company’s disaggregation of revenue by operating segments and products. Practical Expedients The Company elected to apply the following practical expedients when adopting ASU 2014-09: • Accounting for shipping and handling costs that occur before the customer has obtained control of the goods as a fulfillment activity (i.e., expense) instead of as a promised service. • Performance obligations are completed at a point in time which is less than 12 months from when the costs to obtain the contract are incurred. As such, the Company will continue to expense any costs to obtain a contract. Principal Revenue Streams and Significant Judgments Our principal revenue streams can be divided into: i) sale of personal care products primarily through retailers in North America; ii) sale of personal care products through a combination of retailers and distributors internationally; and iii) production and sale of private brands products that are made to customer specifications. Performance Obligations The Company’s revenue is from the sale of its products. Revenue is recognized when the customer obtains control of the goods, which occurs when the ability to use and obtain benefits from the goods are passed to the customer, most commonly upon the delivery of goods to the customer. Discounts are offered to customers for early payment and an estimate of the discounts is recorded as a reduction of Net sales in the same period as the sale. The Company’s standard sales terms are final and returns or exchanges are not permitted with the exception of end of season returns for Sun Care products. Reserves are established and recorded in cases where the right of return does exist for a particular sale. The Company assesses the goods promised in its customers’ purchase orders and identifies a performance obligation to transfer goods (or a bundle of goods) that is distinct. To identify the performance obligations, the Company considers all the goods promised, whether explicitly stated or implied based on customary business practices. The Company’s purchase orders are short term in nature, lasting less than one year and contain a single delivery element. For a purchase order that has more than one performance obligation, the Company allocates the total consideration to each distinct performance obligation on a relative stand-alone selling price basis. The Company does not exclude variable consideration in determining the remaining value of performance obligations. Significant Judgments Under certain circumstances, the Company allows customers to return sun care products that have not been sold by the end of the Sun Care season, which is normal practice in the Sun Care industry. The Company records sales at the time that control of goods pass to the customer. The terms of these sales vary but, in all instances, the following conditions are met: (1) the sales arrangement is evidenced by purchase orders submitted by customers; (2) the selling price is fixed or determinable; (3) title to the product has transferred; (4) there is an obligation to pay at a specified date without any additional conditions or actions required by the Company; and (5) collectability is reasonably assured. Simultaneously with the sale, the Company reduces sales and cost of sales and reserves amounts on its Consolidated Balance Sheet for anticipated returns based upon an estimated return level in accordance with GAAP. Customers are required to pay for the Sun Care product purchased during the season under the required terms. The timing of returns of Sun Care products can vary in different regions based on climate and other factors. However, the majority of returns occur in the U.S. from September through January following the summer Sun Care season. The Company estimates the level of Sun Care returns as the Sun Care season progresses using a variety of inputs including historical experience, consumption trends during the Sun Care season, obsolescence factors including expiration dates, and inventory positions at key retailers. The Company monitors shipment activity and inventory levels at key retailers during the season in an effort to more accurately estimate potential returns. This allows the Company to manage shipment activity to its customers, especially in the latter stages of the Sun Care season, to reduce the potential for returned product. The Company also allows for returns of other products under limited circumstances. Non-Sun Care returns are evaluated each period based on communications with customers and other issues known as of period end. The Company had a reserve for returns of $50.6 and $58.6 at June 30, 2019 and September 30, 2018, respectively. The adoption of ASU 2014-09 required changes in the presentation of returns on the Condensed Consolidated Balance Sheet, namely that a return asset should be recognized for returns expected to be resold, measured at the carrying amount of goods at the time of sale, less the expected costs to recover the goods and any expected reduction in value. The Company had an inventory return asset of $5.3 as of the adoption date. The Company recorded an inventory return asset of $3.2 as of June 30, 2019. The recognition of an inventory return asset resulted in a corresponding increase to the reserve for returns as of June 30, 2019. The inventory return asset and the reserve for returns are included in Other current assets and Other current liabilities, respectively, on the Condensed Consolidated Balance Sheet. In addition, the Company offers a variety of programs, such as consumer coupons and rebate programs, primarily to its retail customers, designed to promote sales of its products. Such programs require periodic payments and allowances based on estimated results of specific programs and are recorded as a reduction to Net sales. The Company accrues, at the time of sale, the estimated total payments and allowances associated with each transaction. Additionally, the Company offers programs directly to consumers to promote the sale of its products. Promotions which reduce the ultimate consumer sale prices are recorded as a reduction of Net sales at the time the promotional offer is made using estimated redemption and participation levels. Taxes the Company collects on behalf of governmental authorities, which are generally included in the price to the customer, are also recorded as a reduction of Net sales. The Company continually assesses the adequacy of accruals for customer and consumer promotional program costs not yet paid. To the extent total program payments differ from estimates, adjustments may be necessary. Historically, these adjustments have not been material. Contract Balances The timing of revenue recognition is based on the customer’s receipt of goods. Standard payment terms with customers require payment after goods have been delivered and risk of ownership has transferred to the customer. The Company has contract liabilities as a result of advanced payments received from certain customers before goods have been delivered and all performance obligations have been completed. Contract liabilities as of the adoption date were $1.3 . Contract liabilities were $0.9 at June 30, 2019 and were classified within Other current liabilities on our Consolidated Balance Sheets. Of the amount deferred, substantially all will be recognized within a year, with the significant majority to be captured within a quarter following deferral. Accounts receivable are stated at their net realizable value. The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the receivables portfolio determined on the basis of historical experience, specific allowances for known troubled accounts, and other currently available information.

Business Combinations and Dives

Business Combinations and Divestiture	9 Months Ended
Business Combinations and Divestiture	Jun. 30, 2019
Business Combinations [Abstract]
Business Combinations and Divestiture	Business Combinations and Divestitures Harry’s, Inc. On May 9, 2019, the Company announced that it entered into a definitive agreement under which the Company will combine with Harry’s, Inc. (“Harry’s”) in a cash and stock transaction that values Harry’s at $1,370 (the “Merger”). Under the terms of the agreement and based on the Company’s closing share price on May 8, 2019, approximately 79% of the total value of the transaction will be paid in cash and 21% will be paid in shares of the Company’s common stock. The Merger has been approved by the respective Board of Directors of the Company and Harry’s and is expected to close in the first quarter of the 2020 calendar year, subject to the satisfaction of customary closing conditions and receipt of regulatory clearances. The Company intends to finance the Merger through new debt and equity. The Merger of the Company and Harry’s brings together complementary capabilities to create a next-generation consumer products platform with an expansive runway for accelerated topline growth and enhanced value creation. The Company incurred costs associated with the acquisition of Harry’s totaling $1.8 for the three and nine months ended June 30, 2019, which were included in SG&A on the Consolidated Statement of Earnings. Jack Black, L.L.C. On March 1, 2018, the Company completed the acquisition of Jack Black, L.L.C. (“Jack Black”), a men’s luxury skincare products company based in the U.S., for $90.2 , net of cash acquired. The acquisition creates opportunities to expand the Company’s personal care portfolio into a growing global category where it can leverage its international geographic footprint. The acquisition was financed through available operating cash. The Company has recognized the assets and liabilities of Jack Black based on estimates of their acquisition date fair values. The determination of the fair values of the acquired assets and assumed liabilities, including goodwill and other intangible assets, requires significant judgment. The Company completed the final fair value determination during the fourth quarter of fiscal 2018. The Company’s purchase price allocation for Jack Black included net assets of $93.9 and consisted of working capital and other net assets of $11.9 (including cash of $3.7 ), other intangible assets of $47.7 and goodwill of $34.3 , representing the value of expansion into new markets. Goodwill is deductible for tax purposes. The intangible assets acquired consisted primarily of the Jack Black trade name, customer relationships and product formulations with a weighted average useful life of 17 years . All assets are included in the Company’s Sun and Skin Care segment. The Company noted the revenues and net earnings of Jack Black from the beginning of the period through the acquisition date were not material relative to the total revenues and net earnings of the Company during fiscal 2018. Acquisition and integration costs related to Jack Black totaling $0.1 and $1.1 for the three and nine months ended June 30, 2019, respectively, were included in SG&A on the Consolidated Statement of Earnings. Acquisition and integration costs related to Jack Black totaling $0.5 and $3.1 for the three and nine months ending June 30, 2018, respectively, were included in SG&A in the Consolidated Statement of Earnings. Additionally, acquisition and integration costs of $1.8 were included in Cost of products sold for the three and nine months ended June 30, 2018. Sale of Playtex Gloves Business On October 3, 2017, the Company entered into an agreement to sell its Playtex gloves business to a household products company (the “Acquirer”) for $19.0 to allow the Company to better focus and utilize its resources on its other product lines. The agreement also provided the Acquirer with indefinite and exclusive worldwide rights to the Playtex trademark for gloves. The sale was completed on October 26, 2017. Total assets sold were approximately $3.7 resulting in a pre-tax gain on sale of $15.3 in fiscal 2018.

Restructuring Charges

Restructuring Charges	9 Months Ended
Restructuring Charges	Jun. 30, 2019
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Project Fuel In February 2018, the Company announced Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of the Company’s business and cost structure, simplifying and transforming the organization, structure, and key processes that will provide the necessary catalyst for further re-investment in the Company’s growth objectives while enabling the Company to achieve its desired future state operations. Initial costs for Project Fuel incurred by the Company were related to efforts to fully define the scope and reach of the project. In addition, the Company has incurred global severance costs related to the reduction of overhead. The Company has incurred costs and realized savings for Project Fuel in fiscal 2018 and for the first nine months of fiscal 2019 and expects to incur additional costs and realize additional savings during the remainder of fiscal 2019 through fiscal 2021. The Company does not include Project Fuel restructuring costs in the results of its reportable segments. The estimated impact of allocating such charges to segment results for fiscal 2019 would have been as follows: Three Months Ended June 30, 2019 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 0.5 $ 0.1 $ — $ — $ 3.0 $ 3.6 Asset impairment and accelerated depreciation 0.5 — — — — 0.5 Consulting, project implementation and management and, other exit costs 0.1 — — — 4.7 4.8 Total Restructuring $ 1.1 $ 0.1 $ — $ — $ 7.7 $ 8.9 Nine Months Ended June 30, 2019 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 12.2 $ 2.3 $ 1.2 $ 0.4 $ 5.8 21.9 Asset impairment and accelerated depreciation 1.0 — — — 0.5 1.5 Consulting, project implementation and management and, other exit costs 2.4 — — — 17.0 19.4 Total Restructuring $ 15.6 $ 2.3 $ 1.2 $ 0.4 $ 23.3 $ 42.8 Three Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 1.6 $ 0.2 $ 1.0 $ 0.1 $ — 2.9 Consulting, project implementation and management and, other exit costs 2.0 0.2 — — 10.8 13.0 Total Restructuring $ 3.6 $ 0.4 $ 1.0 $ 0.1 $ 10.8 $ 15.9 Nine Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 3.1 $ 0.9 $ 1.1 $ 0.1 $ — 5.2 Consulting, project implementation and management and, other exit costs 2.0 0.2 — — 12.2 14.4 Total Restructuring $ 5.1 $ 1.1 $ 1.1 $ 0.1 $ 12.2 $ 19.6 Pre-tax SG&A of $1.8 and $5.1 for the three and nine months ended June 30, 2019, respectively, and $0.5 for the three and nine months ended June 30, 2018, associated with certain information technology enablement expenses related to Project Fuel, were included in Consulting, project implementation and management, and other exit costs. The following table summarizes the restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2019: Utilized October 1, 2018 Charge to Other (1) Cash Non-Cash June 30, 2019 Restructuring Severance and related benefit costs $ 5.1 $ 21.9 $ — $ (16.9 ) $ — $ 10.1 Asset impairment and accelerated depreciation — 1.5 — — (1.5 ) — Consulting, project implementation and management, and other exit costs 2.6 19.4 — (21.4 ) — 0.6 Total Restructuring $ 7.7 $ 42.8 $ — $ (38.3 ) $ (1.5 ) $ 10.7 Utilized October 1, 2017 Charge to Income Other (1) Cash Non-Cash September 30, 2018 Restructuring Severance and related benefit costs $ 2.4 $ 12.1 $ (0.1 ) $ (9.3 ) $ — $ 5.1 Asset impairment and accelerated depreciation — 1.8 — — (1.8 ) $ — Consulting, project implementation and management, and other exit costs — 26.0 — (23.4 ) — 2.6 Total Restructuring $ 2.4 $ 39.9 $ (0.1 ) $ (32.7 ) $ (1.8 ) $ 7.7 (1) Includes the impact of currency translation.

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Jun. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three and nine months ended June 30, 2019, the Company had an income tax benefit of $40.3 and $16.8 , respectively, on Loss before income taxes of $481.7 and $410.4 , respectively. The effective tax rate for the three and nine months ended June 30, 2019 was 8.4% and 4.1% , respectively. The difference between the federal statutory rate and the effective rate is primarily due to the impairment of goodwill and intangible assets, a portion of which are non-deductible, resulting in a lower tax benefit on a net loss. The nine month rate was also unfavorably impacted by a $4.7 net transitional charge resulting from the enactment of the Tax Cuts and Jobs Act (the “Tax Act”) in the first quarter of fiscal 2019, as discussed below. For the three and nine months ended June 30, 2018, the Company had income tax expense of $9.3 and $56.4 , respectively, on Earnings before income taxes of $21.4 and $140.3 , respectively. The effective tax rate for the three and nine months ended June 30, 2018 was 42.9% and 40.2% , respectively. The difference between the federal statutory rate and the effective rate for the nine months ended June 30, 2018 is primarily due to a $17.4 net transitional charge resulting from the enactment of the Tax Act, as discussed below, and the impact of the goodwill impairment. U.S. Tax Reform On December 22, 2017, the U.S. government enacted the Tax Act. This new comprehensive tax legislation reduces the U.S. federal corporate tax rate from 35% to 21% but also limits and/or eliminates certain deductions while creating new taxes on certain foreign sourced earnings. Since the Company has a September 30 fiscal year end, the lower U.S. corporate income tax rate was phased in, resulting in a blended U.S. statutory federal rate of approximately 24.5% for the fiscal year ended September 30, 2018 and 21% for subsequent fiscal years. The reduction in the U.S. corporate tax rate required the Company to remeasure its U.S. deferred tax assets and liabilities to the lower federal rate of 21% . The Tax Act also imposed a one-time transition tax on historical earnings of certain foreign subsidiaries that were not previously taxed by the U.S. For the nine months ended June 30, 2019, the discrete tax adjustment for the one-time transition tax on foreign earnings was $4.7 compared to $94.2 for the nine months ended June 30, 2018. The June 30, 2018 transition tax expense was offset by the estimated benefit of remeasurement of U.S. deferred tax assets and liabilities of $76.8 , resulting in a net charge of $17.4 for the period, which was included as a component of income tax expense. The Company has tax loss carryforwards and tax credits, a portion of which are expected to be used to partially offset amounts payable over eight years related to the one-time transition tax on foreign earnings. Subsequent to the Tax Act, the SEC issued rules under Staff Accounting Bulletin (“SAB”) 118 that allow for a measurement period of up to one year after the enactment date of the Tax Act to finalize the recording of the related tax impacts. As of December 31, 2018, the Company has completed the accounting analysis for the Tax Act under SAB 118 based on current guidance, interpretations, and data available. We will continue to monitor and assess the impact of any new guidance and legislative changes. Due to the Company’s fiscal year end, certain tax provisions of the new Tax Act impacted the Company in fiscal 2018 while others are effective for fiscal year 2019 and beyond. The significant provisions of the Tax Act which the Company is subject to beginning in fiscal 2019 include the full U.S. federal statutory rate reduction to 21% , the repeal of the domestic production activities deduction, tax on global intangible low-taxed income (“GILTI”), base erosion and anti-avoidance tax (“BEAT”), limitation of deductibility of certain executive compensation, limitation on business interest, and a deduction for foreign derived intangible income (“FDII”). The Company has recorded tax liabilities/(benefits) for the various provisions during the first nine months of fiscal 2019. The Tax Act subjects a U.S. corporation to tax on its GILTI. U.S. GAAP allows companies to make an accounting policy election of either (1) treating taxes due on future U.S. inclusions in taxable income related to GILTI as a current-period expense when incurred (the “period cost method”) or (2) factoring such amounts into the Company’s measurement of deferred taxes (the “deferred method”). The Company has made an accounting policy election to treat GILTI taxes as a current period expense. The Company generally repatriates a portion of current year earnings from select non-US subsidiaries only if the economic cost of the repatriation is not considered material. The Company has historically considered the undistributed earnings of our foreign subsidiaries to be indefinitely reinvested and, accordingly, no taxes have been provided on such earnings. We continue to evaluate our plans for reinvestment or repatriation of unremitted foreign earnings and have not changed our previous indefinite reinvestment determination following the enactment of the Tax Act. If we determine that all or a portion of such foreign earnings are no longer indefinitely reinvested, the Company may be subject to additional foreign withholding taxes and U.S. federal and state income taxes beyond the Tax Act’s one-time transition tax.

Earnings per Share

Earnings per Share	9 Months Ended
Earnings per Share	Jun. 30, 2019
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the weighted-average number of common shares outstanding during the period. Diluted earnings per share is based on the number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent (“RSE”) awards. The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Basic weighted-average shares outstanding 54.1 54.0 54.1 54.5 Effect of dilutive securities: RSE awards — 0.1 — 0.1 Total dilutive securities — 0.1 — 0.1 Diluted weighted-average shares outstanding 54.1 54.1 54.1 54.6 For the three and nine months ended June 30, 2019 , the calculation of diluted weighted-average shares outstanding excludes 0.5 of share options because the effect of including these awards was anti-dilutive. For the three and nine months ended June 30, 2019 , the calculation of diluted weighted-average shares outstanding excludes 0.2 of RSE awards that would have otherwise been dilutive, because the Company reported a net loss. For the three and nine months ended June 30, 2018 , the calculation of diluted weighted-average shares outstanding excludes 0.5 of share options because the effect of including these awards was anti-dilutive. For the three and nine months ended June 30, 2018 , the calculation of diluted weighted-average shares outstanding excludes 0.1

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
Goodwill and Intangible Assets	Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Gross balance at October 1, 2018 $ 968.2 $ 229.4 $ 208.0 $ 69.6 $ 1,475.2 Accumulated goodwill impairment — — — (24.4 ) (24.4 ) Net balance at October 1, 2018 $ 968.2 $ 229.4 $ 208.0 $ 45.2 $ 1,450.8 Changes in the nine month period ended June 30, 2019 Impairment charges $ (358.0 ) $ — $ — $ (29.0 ) $ (387.0 ) Cumulative translation adjustment (2.5 ) (0.5 ) (0.6 ) — (3.6 ) Gross balance at June 30, 2019 $ 965.7 $ 228.9 $ 207.4 $ 69.6 $ 1,471.6 Accumulated goodwill impairment (358.0 ) — — (53.4 ) (411.4 ) Net balance at June 30, 2019 $ 607.7 $ 228.9 $ 207.4 $ 16.2 $ 1,060.2 June 30, 2019 September 30, 2018 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 206.6 $ 32.8 $ 173.8 $ 206.7 $ 25.4 $ 181.3 Technology and patents 78.8 76.4 2.4 79.0 75.9 3.1 Customer related and other 178.6 101.3 77.3 179.3 96.2 83.1 Total amortizable intangible assets $ 464.0 $ 210.5 $ 253.5 $ 465.0 $ 197.5 $ 267.5 Amortization expense was $4.4 and $13.4 for the three and nine months ended June 30, 2019 , respectively, and $4.6 and $13.2 for the three and nine months ended June 30, 2018, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2019 and for fiscal 2020, 2021, 2022, 2023, and 2024 is $4.3 , $17.1 , $16.5 , $16.3 , $16.3 , and $16.2 , respectively, and $166.8 thereafter. The Company had indefinite-lived intangible assets of $667.9 ( $180.8 in Wet Shave, $388.4 in Sun and Skin Care, $29.9 in Feminine Care, and $68.8 in All Other) at June 30, 2019 , a decrease of $163.6 from September 30, 2018, resulting from the impairment of the Wet Ones and Diaper Genie trade names. The Company had indefinite-lived trade names and brands of $831.5 ( $182.2 in Wet Shave, $475.6 in Sun and Skin Care, $29.9 in Feminine Care, and $143.8 in All Other) at September 30, 2018. The Company performed an interim impairment analysis using financial information through June 30, 2019 and forecasts for cash flows developed using the Company's three-year strategic plan. The Company’s annual impairment test is performed on July 1. The interim impairment analysis was performed due to the decline in the price of the Company’s common stock in the third quarter of fiscal 2019. The analysis was completed in a manner consistent with the annual impairment test using both the market and income approaches and weighting them based on their application to the reporting units. The interim impairment review was performed across all reporting units and indefinite-lived intangible assets. The analysis indicated that the carrying amount of the goodwill for the Wet Shave and Infant Care reporting units was greater than its fair value. The impairment of the Wet Shave and Infant Care reporting units was calculated as the difference between the fair value, determined in the interim impairment review, and the carrying value. The results of the impairment analysis indicated that the goodwill of the Wet Shave and Infant Care reporting units was impaired $358.0 and $29.0 , respectively, as of June 30, 2019. Additionally, the impairment analysis indicated that the indefinite-lived trade names for Wet Ones and Diaper Genie had carrying values that exceeded their fair values. As a result, the Wet Ones and Diaper Genie trade names were impaired $87.0 and $75.0 , respectively as of June 30, 2019. Additionally, the interim impairment analysis indicated the fair values of the Skin Care and Feminine Care reporting units were between 102% and 105% of their carrying values, respectively. Key assumptions used in valuing the reporting units include the weighted average cost of capital of 9.6% and 7.9% for Skin Care and Feminine Care, respectively. The long-term revenue growth rates applied to the valuation models were 2.00% for Skin Care and 0.50% for Feminine Care. Unfavorable fluctuations in the discount rates or declines in forecasted sales and margins could result in impairment of the reporting units and indefinite-lived trade names. The Company will continue to evaluate the fair value of goodwill and intangible assets through the fourth quarter of fiscal 2019 for potential impairment. During fiscal 2018, the Company recorded impairment charges of $24.4 on the goodwill of the Infant Care reporting unit. The value of the Infant Care reporting unit decreased and required an impairment because of higher discount rates, lower forecasted revenue growth rates, and earnings margins, which resulted in lower projected long-term future cash flows when the interim impairment analysis was performed.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	9 Months Ended
Supplemental Balance Sheet Information	Jun. 30, 2019
Supplemental Balance Sheet Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information June 30, September 30, Inventories Raw materials and supplies $ 52.4 $ 52.0 Work in process 73.4 67.5 Finished products 246.9 210.0 Total inventories $ 372.7 $ 329.5 Other Current Assets Miscellaneous receivables $ 20.0 $ 12.6 Prepaid expenses 74.6 68.4 Value added tax collectible from customers 25.4 25.2 Income taxes receivable 20.1 17.3 Other 2.2 5.3 Total other current assets $ 142.3 $ 128.8 Property, Plant and Equipment Land $ 19.0 $ 19.2 Buildings 137.6 141.9 Machinery and equipment 1,004.0 964.8 Capitalized software costs 47.9 48.4 Construction in progress 27.4 59.9 Total gross property, plant and equipment 1,235.9 1,234.2 Accumulated depreciation and amortization (835.2 ) (810.1 ) Total property, plant and equipment, net $ 400.7 $ 424.1 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 64.9 $ 28.2 Accrued trade allowances 26.7 29.9 Accrued salaries, vacations and incentive compensation 50.9 44.2 Income taxes payable 18.9 20.3 Returns reserve 50.6 58.6 Restructuring reserve 10.7 7.7 Value added tax payable 8.2 4.0 Deferred compensation 6.9 6.3 Other 81.3 86.3 Total other current liabilities $ 319.1 $ 285.5 Other Liabilities Pensions and other retirement benefits $ 87.7 $ 91.5 Deferred compensation 33.1 40.7 Other non-current liabilities 82.2 79.6 Total other liabilities $ 203.0 $ 211.8

Accounts Receivable Facility

Accounts Receivable Facility	9 Months Ended
Accounts Receivable Facility	Jun. 30, 2019
Transfers and Servicing [Abstract]
Accounts receivable facility	Accounts Receivable Facility On September 15, 2017, the Company entered into the Accounts Receivable Facility. Transfers under this agreement are accounted for as sales of receivables, resulting in the receivables being de-recognized from the Consolidated Balance Sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution. The purchase and sale of receivables under the agreement is intended to be an absolute and irrevocable transfer without recourse by the purchaser to the Company for the creditworthiness of any obligor. The Company continues to have collection and servicing responsibilities for the receivables sold and receives separate compensation for their servicing. The compensation received is considered acceptable servicing compensation and, as such, the Company does not recognize a servicing asset or liability. As of June 30, 2019, the discount rate used to determine the purchase price for the subject receivables is based upon LIBOR plus a margin applicable to the specified obligor. Accounts receivables sold under this agreement were $308.2 and $754.2 for the three and nine months ended June 30, 2019, respectively, and $328.5 and $820.1 for the three and nine months ended June 30, 2018, respectively. The trade receivables sold that remained outstanding under this agreement as of June 30, 2019 and September 30, 2018 were $119.2 and $77.9 , respectively. The net proceeds received were included in cash provided by operating activities and cash provided by investing activities on the Consolidated Statement of Cash Flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of receivables in Other expense, net in the Consolidated Statement of Earnings. The loss on sale of trade receivables was $0.9 and $2.2 for the three and nine months ended June 30, 2019, respectively, and the loss on sale of trade receivables was $0.8 and $1.8

Debt

Debt	9 Months Ended
Debt	Jun. 30, 2019
Debt Disclosure [Abstract]
Debt	Debt The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 4.7%, due 2021 $ 600.0 $ 600.0 Senior notes, fixed interest rate of 4.7%, due 2022 500.0 500.0 U.S. revolving credit facility due June 2020 125.0 7.0 Term loan, due 2019 — 185.0 Total long-term debt, including current maturities 1,225.0 1,292.0 Less current portion 125.0 184.9 Less unamortized debt issuance costs and discount (1) (2) 2.5 3.3 Total long-term debt $ 1,097.5 $ 1,103.8 (1) At June 30, 2019 , the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.9 and $1.2 , respectively. At September 30, 2018, the balance for the senior notes due 2021, the senior notes due 2022, and the term loan are reflected net of debt issuance costs of $1.2 , $1.5 and $0.1 , respectively. (2) At June 30, 2019 and September 30, 2018, the balance for the senior notes due 2022 was reflected net of discount of $0.4 and $0.5 , respectively. On February 6, 2019, the Company made a $185.0 prepayment to retire its term loan due April 2019 (the “Term Loan”). The Company funded the payment through additional borrowing on its U.S. revolving credit facility due June 2020 (“Revolving Credit Facility”). The Company had outstanding variable-rate international borrowings recorded in Notes payable, of $12.6 and $8.2 as of June 30, 2019 and September 30, 2018 , respectively. As of June 30, 2019, the Company had outstanding borrowings of $125.0 on the Revolving Credit Facility classified as a current liability. The Company expects to refinance the Revolving Credit Facility prior to its maturity date.

Retirement Plans

Retirement Plans	9 Months Ended
Retirement Plans	Jun. 30, 2019
Retirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries, which are included in the information presented below. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in several other non-U.S. pension and post-retirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company’s net periodic pension and postretirement cost (benefit) for these plans was as follows: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Service cost $ 0.7 $ 0.7 $ 2.2 $ 2.2 Interest cost 4.7 4.3 14.1 12.9 Expected return on plan assets (6.4 ) (7.1 ) (19.0 ) (21.4 ) Recognized net actuarial loss 1.1 1.1 3.1 3.4 Net periodic cost (benefit) $ 0.1 $ (1.0 ) $ 0.4 $ (2.9 ) The service cost component of the net periodic cost (benefit) associated with the Company’s retirement plans is recorded to Cost of products sold and SG&A on the Condensed Consolidated Statement of Earnings. The remaining net periodic cost (benefit) is recorded to Other expense, net on the Condensed Consolidated Statement of Earnings.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
Shareholders' Equity	Jun. 30, 2019
Stockholders' Equity Note [Abstract]
Shareholders' Equity	Shareholders’ Equity In January 2018, the Board approved an authorization to repurchase up to 10.0 shares of the Company’s common stock, replacing the previous stock repurchase authorization from May 2015. The Company did not repurchase any shares under this authorization during the nine months ended June 30, 2019. The Company has 10.0 shares of its common stock available for repurchase in the future under the Board’s authorization. Any future share repurchases may be made in the open market, privately negotiated transactions, or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs, and other factors.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	9 Months Ended
Accumulated Other Comprehensive Loss	Jun. 30, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive (Loss) Income The following table presents the changes in accumulated other comprehensive (loss) income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2018 $ (40.6 ) $ (110.3 ) $ 2.6 $ (148.3 ) OCI before reclassifications (1) (9.4 ) (2.5 ) 0.1 (11.8 ) Reclassifications to earnings — 2.3 (3.1 ) (0.8 ) Balance at June 30, 2019 $ (50.0 ) $ (110.5 ) $ (0.4 ) $ (160.9 ) Foreign Pension and Hedging Total Balance at October 1, 2017 $ (29.0 ) $ (101.3 ) $ (1.1 ) $ (131.4 ) OCI before reclassifications (1) (10.4 ) 0.2 1.2 (9.0 ) Reclassifications to earnings — 2.4 1.7 4.1 Balance at June 30, 2018 $ (39.4 ) $ (98.7 ) $ 1.8 $ (136.3 ) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: For the Three Months Ended For the Nine Months Ended June 30, Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2019 2018 2019 2018 Gain / Loss on cash flow hedges Foreign exchange contracts $ 1.4 $ (1.0 ) $ 4.5 $ (2.5 ) Other expense, net 1.4 (1.0 ) 4.5 (2.5 ) Total before tax 0.4 (0.4 ) 1.4 (0.8 ) Income tax (benefit) provision 1.0 (0.6 ) 3.1 (1.7 ) Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses $ (1.1 ) $ (1.1 ) $ (3.1 ) (3.4 ) (1) (1.1 ) (1.1 ) (3.1 ) (3.4 ) Total before tax (0.3 ) (0.3 ) (0.8 ) (1.0 ) Income tax (benefit) provision (0.8 ) (0.8 ) (2.3 ) $ (2.4 ) Net of tax Total reclassifications for the period $ 0.2 $ (1.4 ) $ 0.8 $ (4.1 ) Net of tax (1) These AOCI components are included in the computation of net periodic cost (benefit). See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	9 Months Ended
Financial Instruments and Risk Management	Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management At times, the Company enters into contractual arrangements (also referred to as derivatives), to reduce its exposure to foreign currency. The Company has master netting agreements with all of its counterparties that allow for the settlement of contracts in an asset position with contracts in a liability position in the event of default. The Company manages counterparty risk through the utilization of investment grade commercial banks, diversification of counterparties, and its counterparty netting arrangements. The section below outlines the types of derivatives that existed at June 30, 2019 and September 30, 2018 , as well as the Company’s objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company’s sales is tied to currencies other than the U.S. dollar, the Company’s reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact on reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the euro, the Japanese yen, the British pound, the Canadian dollar, and the Australian dollar. Additionally, the Company’s foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary’s local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary’s local currency results in an exchange gain or loss recorded in Other expense, net. The primary currency to which the Company’s foreign subsidiaries are exposed is the U.S. dollar. Cash Flow Hedges At June 30, 2019 , the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments had a high correlation to the underlying exposure being hedged and were deemed highly effective for accounting purposes in offsetting the associated risk. The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax loss of $0.5 and a gain of $3.9 at June 30, 2019 and September 30, 2018 , respectively, on these forward currency contracts, which are accounted for as cash flow hedges and included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at June 30, 2019 levels over the next 12 months, the majority of the pre-tax gain included in AOCI at June 30, 2019 is expected to be included in Other expense, net. Contract maturities for these hedges extend into fiscal 2020. At June 30, 2019 , there were 61 open foreign currency contracts with a total notional value of $126.9 . Derivatives not Designated as Hedges The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures and thus are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three and nine months ended June 30, 2019 resulted in losses of $1.1 and $1.7 , respectively, compared to gains of $3.0 and $0.2 for the three and nine months ended June 30, 2018, and was recorded in Other expense, net in the Condensed Consolidated Statements of Earnings. At June 30, 2019, there were six open foreign currency derivative contracts not designated as cash flow hedges, with a total notional value of $56.1 . The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) June 30, 2019 September 30, 2018 Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ (0.5 ) $ 3.9 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ (0.9 ) $ 1.3 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities. The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ (1.5 ) $ 5.4 $ 0.1 $ 1.7 Gain (loss) reclassified from AOCI into income (effective portion) (1) (2) 1.4 (1.0 ) $ 4.5 $ (2.5 ) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ (1.1 ) $ 3.0 $ (1.7 ) $ 0.2 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and were deemed highly effective in offsetting associated risk. (2) Gain (loss) was recorded in Other expense, net. The following table provides financial assets and liabilities for balance sheet offsetting: At June 30, 2019 At September 30, 2018 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 0.7 $ (2.3 ) $ 5.3 $ — Gross amounts offset in the balance sheet — 0.2 (0.1 ) — Net amounts of assets (liabilities) presented in the balance sheet $ 0.7 $ (2.1 ) $ 5.2 $ — (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions or external inputs from inactive markets. Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: June 30, September 30, Liabilities at estimated fair value: Deferred compensation $ (39.8 ) $ (46.9 ) Derivatives - foreign currency contracts (1.4 ) 5.2 Net liabilities at estimated fair value $ (41.2 ) $ (41.7 ) At June 30, 2019 , the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates, and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan. At June 30, 2019 and September 30, 2018 , the Company had no Level 1 or Level 3 financial assets or liabilities, other than pension plan assets. At June 30, 2019 and September 30, 2018 , the fair market value of fixed rate long-term debt was $1,066.7 and $1,061.2 , respectively, compared to its carrying value of $1,100.0 . The estimated fair value of the long-term debt was estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. There was no variable rate debt excluding revolving credit facilities as of June 30, 2019. The estimated fair value of variable-rate debt, which consists of bank debt and excludes revolving credit facilities, was $185.0 at September 30, 2018 compared to its carrying value of $184.9 at September 30, 2018. The estimated fair value was equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on Level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company’s revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings, and the revolving credit agreements have been determined based on Level 2 inputs.

Segment Data

Segment Data	9 Months Ended
Segment Data	Jun. 30, 2019
Segment Reporting [Abstract]
Segment Data	Segment Data For an overview of the Company’s segments, refer to Note 1 to Notes to Condensed Consolidated Financial Statements. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives, the gain on the sale of the Playtex gloves business, and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management’s view on how it evaluates segment performance. The Company’s operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions, and, in most cases, combined sales force and management teams. The Company applies a fully allocated cost basis in which shared business functions are allocated between the segments. Such allocations are estimates and do not represent the costs of such services if performed on a stand-alone basis. Segment net sales and profitability are presented below: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Net Sales Wet Shave $ 327.7 $ 341.1 $ 909.8 $ 980.4 Sun and Skin Care 168.4 162.8 380.3 374.2 Feminine Care 80.9 84.1 230.2 247.0 All Other 32.2 32.6 92.7 95.4 Total net sales $ 609.2 $ 620.6 $ 1,613.0 $ 1,697.0 Segment Profit Wet Shave $ 54.1 $ 55.0 $ 164.8 $ 177.6 Sun and Skin Care 42.2 33.9 82.1 76.3 Feminine Care 15.5 11.0 36.7 25.7 All Other 3.6 5.4 10.8 16.8 Total segment profit 115.4 105.3 294.4 296.4 General corporate and other expenses (13.1 ) (17.7 ) (43.5 ) (55.6 ) Impairment charges (549.0 ) (24.4 ) (549.0 ) (24.4 ) Restructuring and related costs (1) (8.9 ) (15.9 ) (42.8 ) (19.6 ) Harry’s acquisition and integration costs (2) (1.8 ) — (1.8 ) — Feminine and Infant Care evaluation costs (3) (0.5 ) — (1.5 ) — Sun Care reformulation costs (4) (1.0 ) — (1.5 ) — Jack Black acquisition and integration costs (5) (0.1 ) (2.3 ) (1.1 ) (4.9 ) Investor settlement expense (6) — — (0.9 ) — Sale of Playtex gloves — (0.6 ) — 15.3 Amortization of intangibles (4.4 ) (4.6 ) (13.4 ) (13.2 ) Interest and other expense, net (18.3 ) (18.4 ) (49.3 ) (53.7 ) Total (loss) earnings before income taxes $ (481.7 ) $ 21.4 $ (410.4 ) $ 140.3 (1) Restructuring costs associated with Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes that will enable us to achieve our desired future state operations. Includes pre-tax SG&A of $1.8 and $5.1 for the three and nine months ended June 30, 2019, respectively, and $0.5 for the three and nine months ended June 30, 2018 associated with certain information technology enablement expenses for Project Fuel. (2) Acquisition and integration costs related to Harry’s totaling $1.8 for the three and nine months ended June 30, 2019, were included in SG&A on the Consolidated Statement of Earnings. (3) Includes pre-tax SG&A of $0.5 and $1.5 for the three and nine months ended June 30, 2019, respectively, associated with consulting costs for the Company to evaluate segments. (4) Includes pre-tax Cost of products sold of $1.0 and $1.5 for the three and nine months ended June 30, 2019, respectively, associated with supply chain changes on select Sun Care products. (5) Acquisition and integration costs related to Jack Black totaling $0.1 and $1.1 for the three and nine months ended June 30, 2019, respectively, were included in SG&A on the Consolidated Statement of Earnings. Acquisition and integration costs related to Jack Black totaling $0.5 and $3.1 for the three and nine months ending June 30, 2018, respectively, were included in SG&A in the Consolidated Statement of Earnings. Additionally, acquisition and integration costs of $1.8 were included in Cost of products sold for the three and nine months ended June 30, 2018. (6) Includes pre-tax SG&A of $0.9 for the nine months ended June 30, 2019, associated with a settlement with an investor. The following table presents the Company’s net sales by geographic area: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Net Sales to Customers United States $ 362.1 $ 368.8 $ 923.7 $ 967.3 International 247.1 251.8 689.3 729.7 Total net sales $ 609.2 $ 620.6 $ 1,613.0 $ 1,697.0 Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2019 2018 2019 2018 Razors and blades $ 291.3 $ 304.6 $ 807.2 $ 877.5 Sun care products 135.7 132.1 285.2 297.5 Tampons, pads, and liners 80.9 84.1 230.2 247.0 Shaving gels and creams 36.4 36.5 102.6 102.9 Skin care products 32.7 30.7 95.1 76.7 Infant care and other 32.2 32.6 92.7 95.4 Total net sales $ 609.2 $ 620.6 $ 1,613.0 $ 1,697.0

Guarantor and Non-Guarantor Fin

Guarantor and Non-Guarantor Financial Information	9 Months Ended
Guarantor and Non-Guarantor Financial Information	Jun. 30, 2019
Guarantor and Non-Guarantor Financial Information [Abstract]
Guarantor and Non-Guarantor Financial Information	Guarantor and Non-Guarantor Financial Information The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture. Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position, and cash flows of Edgewell Personal Care Company (the “Parent Company” as defined in the Notes), the Guarantors on a combined basis, the Non-Guarantors on a combined basis, and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors, and the Non-Guarantors. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 420.9 $ 276.5 $ (88.2 ) $ 609.2 Cost of products sold — 237.0 168.2 (88.2 ) 317.0 Gross profit — 183.9 108.3 — 292.2 Selling, general and administrative expense — 58.1 36.7 — 94.8 Advertising and sales promotion expense — 58.3 33.5 — 91.8 Research and development expense — 12.9 — — 12.9 Impairment charges — 437.3 111.7 — 549.0 Restructuring charges — 4.8 2.3 — 7.1 Interest expense associated with debt 13.3 2.1 0.2 — 15.6 Other expense, net — 0.6 2.1 — 2.7 Intercompany service fees — (3.1 ) 3.1 — — Equity in earnings of subsidiaries 431.4 92.1 — (523.5 ) — Loss before income taxes (444.7 ) (479.2 ) (81.3 ) 523.5 (481.7 ) Income tax (benefit) provision (3.3 ) (47.8 ) 10.8 — (40.3 ) Net loss $ (441.4 ) $ (431.4 ) $ (92.1 ) $ 523.5 $ (441.4 ) Statements of Comprehensive Income: Net loss $ (441.4 ) $ (431.4 ) $ (92.1 ) $ 523.5 $ (441.4 ) Other comprehensive income, net of tax 10.1 10.1 10.6 (20.7 ) 10.1 Total comprehensive loss $ (431.3 ) $ (421.3 ) $ (81.5 ) $ 502.8 $ (431.3 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,090.6 $ 774.9 $ (252.5 ) $ 1,613.0 Cost of products sold — 651.2 477.7 (252.5 ) 876.4 Gross profit — 439.4 297.2 — 736.6 Selling, general and administrative expense — 171.5 108.7 — 280.2 Advertising and sales promotion expense — 110.8 80.5 — 191.3 Research and development expense — 39.5 — — 39.5 Impairment charges — 437.3 111.7 — 549.0 Restructuring charges — 24.5 13.2 — 37.7 Interest expense associated with debt 40.1 7.3 0.6 — 48.0 Other expense, net — 1.6 (0.3 ) — 1.3 Intercompany service fees — (12.5 ) 12.5 — — Equity in earnings of subsidiaries 363.3 48.6 — (411.9 ) — Loss before income taxes (403.4 ) (389.2 ) (29.7 ) 411.9 (410.4 ) Income tax (benefit) provision (9.8 ) (25.9 ) 18.9 — (16.8 ) Net loss $ (393.6 ) $ (363.3 ) $ (48.6 ) $ 411.9 $ (393.6 ) Statements of Comprehensive Income: Net loss $ (393.6 ) $ (363.3 ) $ (48.6 ) $ 411.9 $ (393.6 ) Other comprehensive income, net of tax (12.6 ) (12.6 ) (11.2 ) 23.8 (12.6 ) Total comprehensive loss $ (406.2 ) $ (375.9 ) $ (59.8 ) $ 435.7 $ (406.2 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 425.1 $ 278.0 $ (82.5 ) $ 620.6 Cost of products sold — 237.5 163.9 (82.5 ) 318.9 Gross profit — 187.6 114.1 — 301.7 Selling, general and administrative expense — 61.6 39.7 — 101.3 Advertising and sales promotion expense — 70.0 35.3 — 105.3 Research and development expense — 14.9 — — 14.9 Impairment charges — 24.4 — — 24.4 Restructuring charges — 13.4 2.0 — 15.4 Gain on sale of Playtex gloves — 0.6 — — 0.6 Interest expense associated with debt 13.4 2.8 0.3 — 16.5 Other (income) expense, net — (0.2 ) 2.1 — 1.9 Intercompany service fees — (3.5 ) 3.5 — — Equity in earnings of subsidiaries (21.9 ) (25.7 ) — 47.6 — Earnings before income taxes 8.5 29.3 31.2 (47.6 ) 21.4 Income tax (benefit) provision (3.6 ) 7.4 5.5 — 9.3 Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Statements of Comprehensive Income: Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Other comprehensive loss, net of tax (30.0 ) (30.0 ) (30.5 ) 60.5 (30.0 ) Total comprehensive income $ (17.9 ) $ (8.1 ) $ (4.8 ) $ 12.9 $ (17.9 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,143.9 $ 788.5 $ (235.4 ) $ 1,697.0 Cost of products sold — 663.7 466.6 (235.4 ) 894.9 Gross profit — 480.2 321.9 — 802.1 Selling, general and administrative expense — 189.0 114.5 — 303.5 Advertising and sales promotion expense — 139.3 90.6 — 229.9 Research and development expense — 46.5 — — 46.5 Impairment charges — 24.4 — — 24.4 Restructuring charges — 15.8 3.3 — 19.1 Sale of Playtex gloves — (15.3 ) — — (15.3 ) Interest expense associated with debt 40.1 11.6 0.8 — 52.5 Other (income) expense, net — (1.1 ) 2.3 — 1.2 Intercompany service fees — (14.6 ) 14.6 — — Equity in earnings of subsidiaries (113.2 ) (79.1 ) — 192.3 — Earnings before income taxes 73.1 163.7 95.8 (192.3 ) 140.3 Income tax (benefit) provision (10.8 ) 50.5 16.7 — 56.4 Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Statements of Comprehensive Income: Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Other comprehensive loss, net of tax (4.9 ) (4.9 ) (6.5 ) 11.4 (4.9 ) Total comprehensive income $ 79.0 $ 108.3 $ 72.6 $ (180.9 ) $ 79.0 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 1.6 $ 277.4 $ — $ 279.0 Trade receivables, net — 60.4 181.2 — 241.6 Inventories — 201.0 171.7 — 372.7 Other current assets — 47.1 95.2 — 142.3 Total current assets — 310.1 725.5 — 1,035.6 Investment in subsidiaries 3,387.8 1,127.1 — (4,514.9 ) — Intercompany receivables, net (1) — 907.9 21.9 (929.8 ) — Property, plant and equipment, net — 295.7 105.0 — 400.7 Goodwill — 762.1 298.1 — 1,060.2 Other intangible assets, net — 714.8 206.6 — 921.4 Other assets 0.8 (0.1 ) 33.7 — 34.4 Total assets $ 3,388.6 $ 4,117.6 $ 1,390.8 $ (5,444.7 ) $ 3,452.3 Liabilities and Shareholders' Equity Current liabilities $ 6.8 $ 445.1 $ 226.7 $ — $ 678.6 Intercompany payables, net (1) 929.8 — — (929.8 ) — Long-term debt 1,097.5 — — — 1,097.5 Deferred income tax liabilities — 98.3 20.4 — 118.7 Other liabilities — 186.4 16.6 — 203.0 Total liabilities 2,034.1 729.8 263.7 (929.8 ) 2,097.8 Total shareholders' equity 1,354.5 3,387.8 1,127.1 (4,514.9 ) 1,354.5 Total liabilities and shareholders' equity $ 3,388.6 $ 4,117.6 $ 1,390.8 $ (5,444.7 ) $ 3,452.3 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 2.5 $ 263.9 $ — $ 266.4 Trade receivables, net — 46.1 180.4 — 226.5 Inventories — 175.4 154.1 — 329.5 Other current assets — 48.8 80.0 — 128.8 Total current assets — 272.8 678.4 — 951.2 Investment in subsidiaries 3,760.0 1,227.4 — (4,987.4 ) — Intercompany receivables, net (1) — 836.1 63.9 (900.0 ) — Property, plant and equipment, net — 316.7 107.4 — 424.1 Goodwill — 1,037.5 413.3 — 1,450.8 Other intangible assets, net — 886.5 212.5 — 1,099.0 Other assets 1.0 0.1 27.1 — 28.2 Total assets $ 3,761.0 $ 4,577.1 $ 1,502.6 $ (5,887.4 ) $ 3,953.3 Liabilities and Shareholders’ Equity Current liabilities $ 19.7 $ 471.8 $ 225.5 $ — $ 717.0 Intercompany payables, net (1) 900.0 — — (900.0 ) — Long-term debt 1,096.7 7.1 — — 1,103.8 Deferred income tax liabilities — 142.6 33.5 — 176.1 Other liabilities — 195.6 16.2 — 211.8 Total liabilities 2,016.4 817.1 275.2 (900.0 ) 2,208.7 Total shareholders’ equity 1,744.6 3,760.0 1,227.4 (4,987.4 ) 1,744.6 Total liabilities and shareholders’ equity $ 3,761.0 $ 4,577.1 $ 1,502.6 $ (5,887.4 ) $ 3,953.3 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow (used by) from operations $ (27.0 ) $ 99.8 $ 70.4 $ (45.0 ) $ 98.2 Cash Flow from Investing Activities Capital expenditures — (22.7 ) (16.0 ) — (38.7 ) Collection of deferred purchase price from accounts receivable sold — 9.0 — — 9.0 Proceeds from sale of assets — 4.0 0.1 — 4.1 Intercompany receivables and payables, net — (29.8 ) — 29.8 — Payment for equity contributions (1.0 ) — — 1.0 — Other, net — (1.3 ) — — (1.3 ) Net cash used by investing activities (1.0 ) (40.8 ) (15.9 ) 30.8 (26.9 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 316.0 — — 316.0 Cash payments on debt with original maturities greater than 90 days — (198.0 ) — — (198.0 ) Term Loan repayment — (185.0 ) — — (185.0 ) Net increase in debt with original maturities of 90 days or less — 1.5 4.2 — 5.7 Intercompany dividend — — (45.0 ) 45.0 — Net financing outflow from the Accounts Receivable Facility — 5.6 — — 5.6 Intercompany receivables and payables, net 29.8 — — (29.8 ) — Proceeds for equity contribution — — 1.0 (1.0 ) — Employee shares withheld for taxes (1.8 ) — — — (1.8 ) Net cash from (used by) financing activities 28.0 (59.9 ) (39.8 ) 14.2 (57.5 ) Effect of exchange rate changes on cash — — (1.2 ) — (1.2 ) Net (decline) increase in cash and cash equivalents — (0.9 ) 13.5 — 12.6 Cash and cash equivalents, beginning of period — 2.5 263.9 — 266.4 Cash and cash equivalents, end of period $ — $ 1.6 $ 277.4 $ — $ 279.0 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from operations $ 126.6 $ 331.4 $ 73.7 $ (350.2 ) $ 181.5 Cash Flow from Investing Activities Capital expenditures — (31.3 ) (10.5 ) — (41.8 ) Acquisitions, net of cash acquired — (90.2 ) — — (90.2 ) Collection of deferred purchase price from accounts receivable sold — 7.2 — — 7.2 Playtex gloves sale — 19.0 — — 19.0 Proceeds from sale of assets — 4.7 — — 4.7 Net cash used by investing activities — (90.6 ) (10.5 ) — (101.1 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 477.0 — — 477.0 Cash payments on debt with original maturities greater than 90 days — (722.0 ) — — (722.0 ) Net increase in debt with original maturities of 90 days or less — (1.2 ) 1.4 — 0.2 Common shares purchased (124.4 ) — — — (124.4 ) Intercompany dividend — — (350.2 ) 350.2 — Net financing inflow from the Accounts Receivable Facility — 4.6 — — 4.6 Employee shares withheld for taxes (2.2 ) — — — (2.2 ) Net cash used by financing activities (126.6 ) (241.6 ) (348.8 ) 350.2 (366.8 ) Effect of exchange rate changes on cash — — 2.0 — 2.0 Net decline in cash and cash equivalents — (0.8 ) (283.6 ) — (284.4 ) Cash and cash equivalents, beginning of period — 6.4 496.5 — 502.9 Cash and cash equivalents, end of period $ — $ 5.6 $ 212.9 $ — $ 218.5

Restructuring Charges (Tables)

Restructuring Charges (Tables)	9 Months Ended
	Jun. 30, 2019
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	The Company does not include Project Fuel restructuring costs in the results of its reportable segments. The estimated impact of allocating such charges to segment results for fiscal 2019 would have been as follows: Three Months Ended June 30, 2019 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 0.5 $ 0.1 $ — $ — $ 3.0 $ 3.6 Asset impairment and accelerated depreciation 0.5 — — — — 0.5 Consulting, project implementation and management and, other exit costs 0.1 — — — 4.7 4.8 Total Restructuring $ 1.1 $ 0.1 $ — $ — $ 7.7 $ 8.9 Nine Months Ended June 30, 2019 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 12.2 $ 2.3 $ 1.2 $ 0.4 $ 5.8 21.9 Asset impairment and accelerated depreciation 1.0 — — — 0.5 1.5 Consulting, project implementation and management and, other exit costs 2.4 — — — 17.0 19.4 Total Restructuring $ 15.6 $ 2.3 $ 1.2 $ 0.4 $ 23.3 $ 42.8 Three Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 1.6 $ 0.2 $ 1.0 $ 0.1 $ — 2.9 Consulting, project implementation and management and, other exit costs 2.0 0.2 — — 10.8 13.0 Total Restructuring $ 3.6 $ 0.4 $ 1.0 $ 0.1 $ 10.8 $ 15.9 Nine Months Ended June 30, 2018 Wet Sun and Skin Care Feminine Care All Other Corporate Total Project Fuel Severance and related benefit costs $ 3.1 $ 0.9 $ 1.1 $ 0.1 $ — 5.2 Consulting, project implementation and management and, other exit costs 2.0 0.2 — — 12.2 14.4 Total Restructuring $ 5.1 $ 1.1 $ 1.1 $ 0.1 $ 12.2 $ 19.6 Pre-tax SG&A of $1.8 and $5.1 for the three and nine months ended June 30, 2019, respectively, and $0.5
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2019: Utilized October 1, 2018 Charge to Other (1) Cash Non-Cash June 30, 2019 Restructuring Severance and related benefit costs $ 5.1 $ 21.9 $ — $ (16.9 ) $ — $ 10.1 Asset impairment and accelerated depreciation — 1.5 — — (1.5 ) — Consulting, project implementation and management, and other exit costs 2.6 19.4 — (21.4 ) — 0.6 Total Restructuring $ 7.7 $ 42.8 $ — $ (38.3 ) $ (1.5 ) $ 10.7 Utilized October 1, 2017 Charge to Income Other (1) Cash Non-Cash September 30, 2018 Restructuring Severance and related benefit costs $ 2.4 $ 12.1 $ (0.1 ) $ (9.3 ) $ — $ 5.1 Asset impairment and accelerated depreciation — 1.8 — — (1.8 ) $ — Consulting, project implementation and management, and other exit costs — 26.0 — (23.4 ) — 2.6 Total Restructuring $ 2.4 $ 39.9 $ (0.1 ) $ (32.7 ) $ (1.8 ) $ 7.7 (1) Includes the impact of currency translation.	[1]

[1]	Includes the impact of currency translation.

Earnings per Share (Tables)

Earnings per Share (Tables)	9 Months Ended
Earnings per Share (Tables)	Jun. 30, 2019
Earnings Per Share [Abstract]
Schedule of Weighted-Average Shares Outstanding	The following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Basic weighted-average shares outstanding 54.1 54.0 54.1 54.5 Effect of dilutive securities: RSE awards — 0.1 — 0.1 Total dilutive securities — 0.1 — 0.1 Diluted weighted-average shares outstanding 54.1 54.1 54.1 54.6

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
Goodwill and Intangible Assets (Tables)	Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Gross balance at October 1, 2018 $ 968.2 $ 229.4 $ 208.0 $ 69.6 $ 1,475.2 Accumulated goodwill impairment — — — (24.4 ) (24.4 ) Net balance at October 1, 2018 $ 968.2 $ 229.4 $ 208.0 $ 45.2 $ 1,450.8 Changes in the nine month period ended June 30, 2019 Impairment charges $ (358.0 ) $ — $ — $ (29.0 ) $ (387.0 ) Cumulative translation adjustment (2.5 ) (0.5 ) (0.6 ) — (3.6 ) Gross balance at June 30, 2019 $ 965.7 $ 228.9 $ 207.4 $ 69.6 $ 1,471.6 Accumulated goodwill impairment (358.0 ) — — (53.4 ) (411.4 ) Net balance at June 30, 2019 $ 607.7 $ 228.9 $ 207.4 $ 16.2 $ 1,060.2
Schedule of Amortizable Intangible Assets	June 30, 2019 September 30, 2018 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 206.6 $ 32.8 $ 173.8 $ 206.7 $ 25.4 $ 181.3 Technology and patents 78.8 76.4 2.4 79.0 75.9 3.1 Customer related and other 178.6 101.3 77.3 179.3 96.2 83.1 Total amortizable intangible assets $ 464.0 $ 210.5 $ 253.5 $ 465.0 $ 197.5 $ 267.5

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	9 Months Ended
Supplemental Balance Sheet Information (Tables)	Jun. 30, 2019
Supplemental Balance Sheet Information [Abstract]
Supplement Balance Sheet Information	June 30, September 30, Inventories Raw materials and supplies $ 52.4 $ 52.0 Work in process 73.4 67.5 Finished products 246.9 210.0 Total inventories $ 372.7 $ 329.5 Other Current Assets Miscellaneous receivables $ 20.0 $ 12.6 Prepaid expenses 74.6 68.4 Value added tax collectible from customers 25.4 25.2 Income taxes receivable 20.1 17.3 Other 2.2 5.3 Total other current assets $ 142.3 $ 128.8 Property, Plant and Equipment Land $ 19.0 $ 19.2 Buildings 137.6 141.9 Machinery and equipment 1,004.0 964.8 Capitalized software costs 47.9 48.4 Construction in progress 27.4 59.9 Total gross property, plant and equipment 1,235.9 1,234.2 Accumulated depreciation and amortization (835.2 ) (810.1 ) Total property, plant and equipment, net $ 400.7 $ 424.1 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 64.9 $ 28.2 Accrued trade allowances 26.7 29.9 Accrued salaries, vacations and incentive compensation 50.9 44.2 Income taxes payable 18.9 20.3 Returns reserve 50.6 58.6 Restructuring reserve 10.7 7.7 Value added tax payable 8.2 4.0 Deferred compensation 6.9 6.3 Other 81.3 86.3 Total other current liabilities $ 319.1 $ 285.5 Other Liabilities Pensions and other retirement benefits $ 87.7 $ 91.5 Deferred compensation 33.1 40.7 Other non-current liabilities 82.2 79.6 Total other liabilities $ 203.0 $ 211.8

Debt (Tables)

Debt (Tables)	9 Months Ended
Debt (Tables)	Jun. 30, 2019
Debt Disclosure [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: June 30, September 30, Senior notes, fixed interest rate of 4.7%, due 2021 $ 600.0 $ 600.0 Senior notes, fixed interest rate of 4.7%, due 2022 500.0 500.0 U.S. revolving credit facility due June 2020 125.0 7.0 Term loan, due 2019 — 185.0 Total long-term debt, including current maturities 1,225.0 1,292.0 Less current portion 125.0 184.9 Less unamortized debt issuance costs and discount (1) (2) 2.5 3.3 Total long-term debt $ 1,097.5 $ 1,103.8 (1) At June 30, 2019 , the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.9 and $1.2 , respectively. At September 30, 2018, the balance for the senior notes due 2021, the senior notes due 2022, and the term loan are reflected net of debt issuance costs of $1.2 , $1.5 and $0.1 , respectively. (2) At June 30, 2019 and September 30, 2018, the balance for the senior notes due 2022 was reflected net of discount of $0.4 and $0.5 , respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	9 Months Ended
Retirement Plans (Tables)	Jun. 30, 2019
Retirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Cost (Benefit)	The Company’s net periodic pension and postretirement cost (benefit) for these plans was as follows: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Service cost $ 0.7 $ 0.7 $ 2.2 $ 2.2 Interest cost 4.7 4.3 14.1 12.9 Expected return on plan assets (6.4 ) (7.1 ) (19.0 ) (21.4 ) Recognized net actuarial loss 1.1 1.1 3.1 3.4 Net periodic cost (benefit) $ 0.1 $ (1.0 ) $ 0.4 $ (2.9 )

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Jun. 30, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Changes in Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive (loss) income (“AOCI”), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2018 $ (40.6 ) $ (110.3 ) $ 2.6 $ (148.3 ) OCI before reclassifications (1) (9.4 ) (2.5 ) 0.1 (11.8 ) Reclassifications to earnings — 2.3 (3.1 ) (0.8 ) Balance at June 30, 2019 $ (50.0 ) $ (110.5 ) $ (0.4 ) $ (160.9 ) Foreign Pension and Hedging Total Balance at October 1, 2017 $ (29.0 ) $ (101.3 ) $ (1.1 ) $ (131.4 ) OCI before reclassifications (1) (10.4 ) 0.2 1.2 (9.0 ) Reclassifications to earnings — 2.4 1.7 4.1 Balance at June 30, 2018 $ (39.4 ) $ (98.7 ) $ 1.8 $ (136.3 ) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: For the Three Months Ended For the Nine Months Ended June 30, Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2019 2018 2019 2018 Gain / Loss on cash flow hedges Foreign exchange contracts $ 1.4 $ (1.0 ) $ 4.5 $ (2.5 ) Other expense, net 1.4 (1.0 ) 4.5 (2.5 ) Total before tax 0.4 (0.4 ) 1.4 (0.8 ) Income tax (benefit) provision 1.0 (0.6 ) 3.1 (1.7 ) Net of tax Amortization of defined benefit pension and postretirement items Actuarial losses $ (1.1 ) $ (1.1 ) $ (3.1 ) (3.4 ) (1) (1.1 ) (1.1 ) (3.1 ) (3.4 ) Total before tax (0.3 ) (0.3 ) (0.8 ) (1.0 ) Income tax (benefit) provision (0.8 ) (0.8 ) (2.3 ) $ (2.4 ) Net of tax Total reclassifications for the period $ 0.2 $ (1.4 ) $ 0.8 $ (4.1 ) Net of tax (1) These AOCI components are included in the computation of net periodic cost (benefit). See Note 11 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	9 Months Ended
Financial Instruments and Risk Management (Tables)	Jun. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Values of Derivative Instruments	The following table provides estimated fair values of derivative instruments: Fair Value of Asset (Liability) (1) June 30, 2019 September 30, 2018 Derivatives designated as cash flow hedging relationships: Foreign currency contracts $ (0.5 ) $ 3.9 Derivatives not designated as cash flow hedging relationships: Foreign currency contracts $ (0.9 ) $ 1.3 (1) All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Gains and Losses on Derivative Instruments	The following table provides the amounts of gains and losses on derivative instruments: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Derivatives designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in OCI (1) $ (1.5 ) $ 5.4 $ 0.1 $ 1.7 Gain (loss) reclassified from AOCI into income (effective portion) (1) (2) 1.4 (1.0 ) $ 4.5 $ (2.5 ) Derivatives not designated as cash flow hedging relationships: Foreign currency contracts Gain (loss) recognized in income (2) $ (1.1 ) $ 3.0 $ (1.7 ) $ 0.2 (1) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and were deemed highly effective in offsetting associated risk. (2) Gain (loss) was recorded in Other expense, net.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: At June 30, 2019 At September 30, 2018 Assets (1) Liabilities (2) Assets (1) Liabilities (2) Foreign currency contracts Gross amounts of recognized assets (liabilities) $ 0.7 $ (2.3 ) $ 5.3 $ — Gross amounts offset in the balance sheet — 0.2 (0.1 ) — Net amounts of assets (liabilities) presented in the balance sheet $ 0.7 $ (2.1 ) $ 5.2 $ — (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities.
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company’s financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as Level 2 within the fair value hierarchy: June 30, September 30, Liabilities at estimated fair value: Deferred compensation $ (39.8 ) $ (46.9 ) Derivatives - foreign currency contracts (1.4 ) 5.2 Net liabilities at estimated fair value $ (41.2 ) $ (41.7 )

Segment Data (Tables)

Segment Data (Tables)	9 Months Ended
Segment Data (Tables)	Jun. 30, 2019
Segment Reporting [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Net Sales Wet Shave $ 327.7 $ 341.1 $ 909.8 $ 980.4 Sun and Skin Care 168.4 162.8 380.3 374.2 Feminine Care 80.9 84.1 230.2 247.0 All Other 32.2 32.6 92.7 95.4 Total net sales $ 609.2 $ 620.6 $ 1,613.0 $ 1,697.0 Segment Profit Wet Shave $ 54.1 $ 55.0 $ 164.8 $ 177.6 Sun and Skin Care 42.2 33.9 82.1 76.3 Feminine Care 15.5 11.0 36.7 25.7 All Other 3.6 5.4 10.8 16.8 Total segment profit 115.4 105.3 294.4 296.4 General corporate and other expenses (13.1 ) (17.7 ) (43.5 ) (55.6 ) Impairment charges (549.0 ) (24.4 ) (549.0 ) (24.4 ) Restructuring and related costs (1) (8.9 ) (15.9 ) (42.8 ) (19.6 ) Harry’s acquisition and integration costs (2) (1.8 ) — (1.8 ) — Feminine and Infant Care evaluation costs (3) (0.5 ) — (1.5 ) — Sun Care reformulation costs (4) (1.0 ) — (1.5 ) — Jack Black acquisition and integration costs (5) (0.1 ) (2.3 ) (1.1 ) (4.9 ) Investor settlement expense (6) — — (0.9 ) — Sale of Playtex gloves — (0.6 ) — 15.3 Amortization of intangibles (4.4 ) (4.6 ) (13.4 ) (13.2 ) Interest and other expense, net (18.3 ) (18.4 ) (49.3 ) (53.7 ) Total (loss) earnings before income taxes $ (481.7 ) $ 21.4 $ (410.4 ) $ 140.3 (1) Restructuring costs associated with Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes that will enable us to achieve our desired future state operations. Includes pre-tax SG&A of $1.8 and $5.1 for the three and nine months ended June 30, 2019, respectively, and $0.5 for the three and nine months ended June 30, 2018 associated with certain information technology enablement expenses for Project Fuel. (2) Acquisition and integration costs related to Harry’s totaling $1.8 for the three and nine months ended June 30, 2019, were included in SG&A on the Consolidated Statement of Earnings. (3) Includes pre-tax SG&A of $0.5 and $1.5 for the three and nine months ended June 30, 2019, respectively, associated with consulting costs for the Company to evaluate segments. (4) Includes pre-tax Cost of products sold of $1.0 and $1.5 for the three and nine months ended June 30, 2019, respectively, associated with supply chain changes on select Sun Care products. (5) Acquisition and integration costs related to Jack Black totaling $0.1 and $1.1 for the three and nine months ended June 30, 2019, respectively, were included in SG&A on the Consolidated Statement of Earnings. Acquisition and integration costs related to Jack Black totaling $0.5 and $3.1 for the three and nine months ending June 30, 2018, respectively, were included in SG&A in the Consolidated Statement of Earnings. Additionally, acquisition and integration costs of $1.8 were included in Cost of products sold for the three and nine months ended June 30, 2018. (6) Includes pre-tax SG&A of $0.9 for the nine months ended June 30, 2019, associated with a settlement with an investor.
Schedule of Sales by Geographic Area	The following table presents the Company’s net sales by geographic area: Three Months Ended June 30, Nine Months Ended June 30, 2019 2018 2019 2018 Net Sales to Customers United States $ 362.1 $ 368.8 $ 923.7 $ 967.3 International 247.1 251.8 689.3 729.7 Total net sales $ 609.2 $ 620.6 $ 1,613.0 $ 1,697.0
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Nine Months Ended 2019 2018 2019 2018 Razors and blades $ 291.3 $ 304.6 $ 807.2 $ 877.5 Sun care products 135.7 132.1 285.2 297.5 Tampons, pads, and liners 80.9 84.1 230.2 247.0 Shaving gels and creams 36.4 36.5 102.6 102.9 Skin care products 32.7 30.7 95.1 76.7 Infant care and other 32.2 32.6 92.7 95.4 Total net sales $ 609.2 $ 620.6 $ 1,613.0 $ 1,697.0

Guarantor and Non-Guarantor F_2

Guarantor and Non-Guarantor Financial Information (Tables)	9 Months Ended
Guarantor and Non-Guarantor Financial Information (Tables)	Jun. 30, 2019
Guarantor and Non-Guarantor Financial Information [Abstract]
Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 420.9 $ 276.5 $ (88.2 ) $ 609.2 Cost of products sold — 237.0 168.2 (88.2 ) 317.0 Gross profit — 183.9 108.3 — 292.2 Selling, general and administrative expense — 58.1 36.7 — 94.8 Advertising and sales promotion expense — 58.3 33.5 — 91.8 Research and development expense — 12.9 — — 12.9 Impairment charges — 437.3 111.7 — 549.0 Restructuring charges — 4.8 2.3 — 7.1 Interest expense associated with debt 13.3 2.1 0.2 — 15.6 Other expense, net — 0.6 2.1 — 2.7 Intercompany service fees — (3.1 ) 3.1 — — Equity in earnings of subsidiaries 431.4 92.1 — (523.5 ) — Loss before income taxes (444.7 ) (479.2 ) (81.3 ) 523.5 (481.7 ) Income tax (benefit) provision (3.3 ) (47.8 ) 10.8 — (40.3 ) Net loss $ (441.4 ) $ (431.4 ) $ (92.1 ) $ 523.5 $ (441.4 ) Statements of Comprehensive Income: Net loss $ (441.4 ) $ (431.4 ) $ (92.1 ) $ 523.5 $ (441.4 ) Other comprehensive income, net of tax 10.1 10.1 10.6 (20.7 ) 10.1 Total comprehensive loss $ (431.3 ) $ (421.3 ) $ (81.5 ) $ 502.8 $ (431.3 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,090.6 $ 774.9 $ (252.5 ) $ 1,613.0 Cost of products sold — 651.2 477.7 (252.5 ) 876.4 Gross profit — 439.4 297.2 — 736.6 Selling, general and administrative expense — 171.5 108.7 — 280.2 Advertising and sales promotion expense — 110.8 80.5 — 191.3 Research and development expense — 39.5 — — 39.5 Impairment charges — 437.3 111.7 — 549.0 Restructuring charges — 24.5 13.2 — 37.7 Interest expense associated with debt 40.1 7.3 0.6 — 48.0 Other expense, net — 1.6 (0.3 ) — 1.3 Intercompany service fees — (12.5 ) 12.5 — — Equity in earnings of subsidiaries 363.3 48.6 — (411.9 ) — Loss before income taxes (403.4 ) (389.2 ) (29.7 ) 411.9 (410.4 ) Income tax (benefit) provision (9.8 ) (25.9 ) 18.9 — (16.8 ) Net loss $ (393.6 ) $ (363.3 ) $ (48.6 ) $ 411.9 $ (393.6 ) Statements of Comprehensive Income: Net loss $ (393.6 ) $ (363.3 ) $ (48.6 ) $ 411.9 $ (393.6 ) Other comprehensive income, net of tax (12.6 ) (12.6 ) (11.2 ) 23.8 (12.6 ) Total comprehensive loss $ (406.2 ) $ (375.9 ) $ (59.8 ) $ 435.7 $ (406.2 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 425.1 $ 278.0 $ (82.5 ) $ 620.6 Cost of products sold — 237.5 163.9 (82.5 ) 318.9 Gross profit — 187.6 114.1 — 301.7 Selling, general and administrative expense — 61.6 39.7 — 101.3 Advertising and sales promotion expense — 70.0 35.3 — 105.3 Research and development expense — 14.9 — — 14.9 Impairment charges — 24.4 — — 24.4 Restructuring charges — 13.4 2.0 — 15.4 Gain on sale of Playtex gloves — 0.6 — — 0.6 Interest expense associated with debt 13.4 2.8 0.3 — 16.5 Other (income) expense, net — (0.2 ) 2.1 — 1.9 Intercompany service fees — (3.5 ) 3.5 — — Equity in earnings of subsidiaries (21.9 ) (25.7 ) — 47.6 — Earnings before income taxes 8.5 29.3 31.2 (47.6 ) 21.4 Income tax (benefit) provision (3.6 ) 7.4 5.5 — 9.3 Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Statements of Comprehensive Income: Net earnings $ 12.1 $ 21.9 $ 25.7 $ (47.6 ) $ 12.1 Other comprehensive loss, net of tax (30.0 ) (30.0 ) (30.5 ) 60.5 (30.0 ) Total comprehensive income $ (17.9 ) $ (8.1 ) $ (4.8 ) $ 12.9 $ (17.9 ) EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 1,143.9 $ 788.5 $ (235.4 ) $ 1,697.0 Cost of products sold — 663.7 466.6 (235.4 ) 894.9 Gross profit — 480.2 321.9 — 802.1 Selling, general and administrative expense — 189.0 114.5 — 303.5 Advertising and sales promotion expense — 139.3 90.6 — 229.9 Research and development expense — 46.5 — — 46.5 Impairment charges — 24.4 — — 24.4 Restructuring charges — 15.8 3.3 — 19.1 Sale of Playtex gloves — (15.3 ) — — (15.3 ) Interest expense associated with debt 40.1 11.6 0.8 — 52.5 Other (income) expense, net — (1.1 ) 2.3 — 1.2 Intercompany service fees — (14.6 ) 14.6 — — Equity in earnings of subsidiaries (113.2 ) (79.1 ) — 192.3 — Earnings before income taxes 73.1 163.7 95.8 (192.3 ) 140.3 Income tax (benefit) provision (10.8 ) 50.5 16.7 — 56.4 Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Statements of Comprehensive Income: Net earnings $ 83.9 $ 113.2 $ 79.1 $ (192.3 ) $ 83.9 Other comprehensive loss, net of tax (4.9 ) (4.9 ) (6.5 ) 11.4 (4.9 ) Total comprehensive income $ 79.0 $ 108.3 $ 72.6 $ (180.9 ) $ 79.0
Schedule of Condensed Consolidating Balance Sheets	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 1.6 $ 277.4 $ — $ 279.0 Trade receivables, net — 60.4 181.2 — 241.6 Inventories — 201.0 171.7 — 372.7 Other current assets — 47.1 95.2 — 142.3 Total current assets — 310.1 725.5 — 1,035.6 Investment in subsidiaries 3,387.8 1,127.1 — (4,514.9 ) — Intercompany receivables, net (1) — 907.9 21.9 (929.8 ) — Property, plant and equipment, net — 295.7 105.0 — 400.7 Goodwill — 762.1 298.1 — 1,060.2 Other intangible assets, net — 714.8 206.6 — 921.4 Other assets 0.8 (0.1 ) 33.7 — 34.4 Total assets $ 3,388.6 $ 4,117.6 $ 1,390.8 $ (5,444.7 ) $ 3,452.3 Liabilities and Shareholders' Equity Current liabilities $ 6.8 $ 445.1 $ 226.7 $ — $ 678.6 Intercompany payables, net (1) 929.8 — — (929.8 ) — Long-term debt 1,097.5 — — — 1,097.5 Deferred income tax liabilities — 98.3 20.4 — 118.7 Other liabilities — 186.4 16.6 — 203.0 Total liabilities 2,034.1 729.8 263.7 (929.8 ) 2,097.8 Total shareholders' equity 1,354.5 3,387.8 1,127.1 (4,514.9 ) 1,354.5 Total liabilities and shareholders' equity $ 3,388.6 $ 4,117.6 $ 1,390.8 $ (5,444.7 ) $ 3,452.3 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 2.5 $ 263.9 $ — $ 266.4 Trade receivables, net — 46.1 180.4 — 226.5 Inventories — 175.4 154.1 — 329.5 Other current assets — 48.8 80.0 — 128.8 Total current assets — 272.8 678.4 — 951.2 Investment in subsidiaries 3,760.0 1,227.4 — (4,987.4 ) — Intercompany receivables, net (1) — 836.1 63.9 (900.0 ) — Property, plant and equipment, net — 316.7 107.4 — 424.1 Goodwill — 1,037.5 413.3 — 1,450.8 Other intangible assets, net — 886.5 212.5 — 1,099.0 Other assets 1.0 0.1 27.1 — 28.2 Total assets $ 3,761.0 $ 4,577.1 $ 1,502.6 $ (5,887.4 ) $ 3,953.3 Liabilities and Shareholders’ Equity Current liabilities $ 19.7 $ 471.8 $ 225.5 $ — $ 717.0 Intercompany payables, net (1) 900.0 — — (900.0 ) — Long-term debt 1,096.7 7.1 — — 1,103.8 Deferred income tax liabilities — 142.6 33.5 — 176.1 Other liabilities — 195.6 16.2 — 211.8 Total liabilities 2,016.4 817.1 275.2 (900.0 ) 2,208.7 Total shareholders’ equity 1,744.6 3,760.0 1,227.4 (4,987.4 ) 1,744.6 Total liabilities and shareholders’ equity $ 3,761.0 $ 4,577.1 $ 1,502.6 $ (5,887.4 ) $ 3,953.3 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business.
Schedule of Condensed Consolidating Statements of Cash Flows	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2019 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow (used by) from operations $ (27.0 ) $ 99.8 $ 70.4 $ (45.0 ) $ 98.2 Cash Flow from Investing Activities Capital expenditures — (22.7 ) (16.0 ) — (38.7 ) Collection of deferred purchase price from accounts receivable sold — 9.0 — — 9.0 Proceeds from sale of assets — 4.0 0.1 — 4.1 Intercompany receivables and payables, net — (29.8 ) — 29.8 — Payment for equity contributions (1.0 ) — — 1.0 — Other, net — (1.3 ) — — (1.3 ) Net cash used by investing activities (1.0 ) (40.8 ) (15.9 ) 30.8 (26.9 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 316.0 — — 316.0 Cash payments on debt with original maturities greater than 90 days — (198.0 ) — — (198.0 ) Term Loan repayment — (185.0 ) — — (185.0 ) Net increase in debt with original maturities of 90 days or less — 1.5 4.2 — 5.7 Intercompany dividend — — (45.0 ) 45.0 — Net financing outflow from the Accounts Receivable Facility — 5.6 — — 5.6 Intercompany receivables and payables, net 29.8 — — (29.8 ) — Proceeds for equity contribution — — 1.0 (1.0 ) — Employee shares withheld for taxes (1.8 ) — — — (1.8 ) Net cash from (used by) financing activities 28.0 (59.9 ) (39.8 ) 14.2 (57.5 ) Effect of exchange rate changes on cash — — (1.2 ) — (1.2 ) Net (decline) increase in cash and cash equivalents — (0.9 ) 13.5 — 12.6 Cash and cash equivalents, beginning of period — 2.5 263.9 — 266.4 Cash and cash equivalents, end of period $ — $ 1.6 $ 277.4 $ — $ 279.0 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Nine Months Ended June 30, 2018 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from operations $ 126.6 $ 331.4 $ 73.7 $ (350.2 ) $ 181.5 Cash Flow from Investing Activities Capital expenditures — (31.3 ) (10.5 ) — (41.8 ) Acquisitions, net of cash acquired — (90.2 ) — — (90.2 ) Collection of deferred purchase price from accounts receivable sold — 7.2 — — 7.2 Playtex gloves sale — 19.0 — — 19.0 Proceeds from sale of assets — 4.7 — — 4.7 Net cash used by investing activities — (90.6 ) (10.5 ) — (101.1 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 477.0 — — 477.0 Cash payments on debt with original maturities greater than 90 days — (722.0 ) — — (722.0 ) Net increase in debt with original maturities of 90 days or less — (1.2 ) 1.4 — 0.2 Common shares purchased (124.4 ) — — — (124.4 ) Intercompany dividend — — (350.2 ) 350.2 — Net financing inflow from the Accounts Receivable Facility — 4.6 — — 4.6 Employee shares withheld for taxes (2.2 ) — — — (2.2 ) Net cash used by financing activities (126.6 ) (241.6 ) (348.8 ) 350.2 (366.8 ) Effect of exchange rate changes on cash — — 2.0 — 2.0 Net decline in cash and cash equivalents — (0.8 ) (283.6 ) — (284.4 ) Cash and cash equivalents, beginning of period — 6.4 496.5 — 502.9 Cash and cash equivalents, end of period $ — $ 5.6 $ 212.9 $ — $ 218.5

Background and Basis of Prese_2

Background and Basis of Presentation (Details) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019USD ($)brandscountry	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)brandscountry	Jun. 30, 2018USD ($)	Oct. 01, 2018USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of brands \| brands	25		25
Number of countries in which Edgewell operates \| country	50		50
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Collection of deferred purchase price from accounts receivable sold			$ 9	$ 7.2
Selling, general and administrative expense	$ 94.8	$ 101.3	280.2	303.5
Cost of products sold	317	318.9	876.4	894.9
Other expense, net	(2.7)	(1.9)	(1.3)	(1.2)
Accounting standards update 2016-06
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impact of adoption of new accounting pronouncements	$ 3.9		$ 3.9
Accounting standards update 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Selling, general and administrative expense		1		3
Cost of products sold		0.6		2.1
Other expense, net		$ 1.6		$ 5.1
Miscellaneous receivables \| Accounting standards update 2014-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impact of adoption of new accounting pronouncements					$ 5.3
Other current liabilities \| Accounting standards update 2014-09
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impact of adoption of new accounting pronouncements					1.3
Retained earnings \| Accounting standards update 2016-06
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impact of adoption of new accounting pronouncements					$ 3.9

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Details) - USD ($) $ in Millions	Jun. 30, 2019	Oct. 01, 2018	Sep. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Returns reserve	$ 50.6		$ 58.6
Miscellaneous receivables
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Inventory return asset	3.2
Other current liabilities
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract liability	$ 0.9
Accounting standards update 2014-09 \| Miscellaneous receivables
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impact of adoption of new accounting pronouncements		$ 5.3
Accounting standards update 2014-09 \| Other current liabilities
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impact of adoption of new accounting pronouncements		$ 1.3

Business Combinations and Div_2

Business Combinations and Divestiture (Details) - USD ($) $ in Millions		Mar. 01, 2018	Oct. 03, 2017	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Business Acquisition [Line Items]
Business combination, transaction price						$ 1,370
Acquisitions, net of cash acquired						0	$ 90.2
Goodwill				$ 1,060.2		1,060.2		$ 1,450.8
Divestiture
Playtex gloves sale						0	19
Harry's
Business Acquisition [Line Items]
Acquisition and integration costs	[1]			1.8	$ 0	1.8	0
Jack Black
Business Acquisition [Line Items]
Acquisitions, net of cash acquired		$ 90.2
Business combinations, net assets acquired		93.9
Business combinations, working capital and other net assets		11.9
Business combination, cash acquired		3.7
Business combination, other intangible assets		47.7
Goodwill		$ 34.3
Weighted average useful life of intangible assets acquired		17 years
Acquisition and integration costs	[2]			0.1	2.3	1.1	4.9
Selling, general and administrative expenses \| Harry's
Business Acquisition [Line Items]
Acquisition and integration costs				1.8		1.8
Selling, general and administrative expenses \| Jack Black
Business Acquisition [Line Items]
Acquisition and integration costs				$ 0.1	0.5	$ 1.1	3.1
Cost of products sold \| Jack Black
Business Acquisition [Line Items]
Acquisition and integration costs					$ 1.8		1.8
Playtex gloves \| Sale
Divestiture
Playtex gloves sale			$ 19
Value of disposed assets			$ 3.7
Gain on disposal							$ 15.3

[1]	Acquisition and integration costs related to Harry’s totaling $1.8 for the three and nine months ended June 30, 2019, were included in SG&A on the Consolidated Statement of Earnings.
[2]	Acquisition and integration costs related to Jack Black totaling $0.1 and $1.1 for the three and nine months ended June 30, 2019, respectively, were included in SG&A on the Consolidated Statement of Earnings. Acquisition and integration costs related to Jack Black totaling $0.5 and $3.1 for the three and nine months ending June 30, 2018, respectively, were included in SG&A in the Consolidated Statement of Earnings. Additionally, acquisition and integration costs of $1.8 were included in Cost of products sold for the three and nine months ended June 30, 2018.

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended		12 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Restructuring Cost and Reserve [Line Items]
Total Restructuring		$ 7.1	$ 15.4	$ 37.7	$ 19.1
Restructuring and related costs	[1]	8.9	15.9	42.8	19.6
Project Fuel
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		3.6	2.9	21.9	5.2
Asset impairment and accelerated depreciation		0.5		1.5
Consulting, program management and other exit costs		4.8	13	19.4	14.4
Total Restructuring		8.9	15.9	42.8	19.6	$ 39.9
Project Fuel \| Wet Shave
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0.5	1.6	12.2	3.1
Asset impairment and accelerated depreciation		0.5		1
Consulting, program management and other exit costs		0.1	2	2.4	2
Total Restructuring		1.1	3.6	15.6	5.1
Project Fuel \| Sun and Skin Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0.1	0.2	2.3	0.9
Asset impairment and accelerated depreciation		0		0
Consulting, program management and other exit costs		0	0.2	0	0.2
Total Restructuring		0.1	0.4	2.3	1.1
Project Fuel \| Feminine Care
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0	1	1.2	1.1
Asset impairment and accelerated depreciation		0		0
Consulting, program management and other exit costs		0	0	0	0
Total Restructuring		0	1	1.2	1.1
Project Fuel \| All Other
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		0	0.1	0.4	0.1
Asset impairment and accelerated depreciation		0		0
Consulting, program management and other exit costs		0	0	0	0
Total Restructuring		0	0.1	0.4	0.1
Project Fuel \| Corporate
Restructuring Cost and Reserve [Line Items]
Severance and related benefit costs		3	0	5.8	0
Asset impairment and accelerated depreciation		0		0.5
Consulting, program management and other exit costs		4.7	10.8	17	12.2
Total Restructuring		7.7	10.8	23.3	12.2
IT enablement \| Selling, general and administrative expenses \| Project Fuel
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs		$ 1.8	$ 0.5	$ 5.1	$ 0.5

[1]	Restructuring costs associated with Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes that will enable us to achieve our desired future state operations. Includes pre-tax SG&A of $1.8 and $5.1 for the three and nine months ended June 30, 2019, respectively, and $0.5 for the three and nine months ended June 30, 2018 associated with certain information technology enablement expenses for Project Fuel.

Restructuring Charges (Schedu_2

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended		12 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Restructuring Reserve [Roll Forward]
Restructuring charges		$ 7.1	$ 15.4	$ 37.7	$ 19.1
Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				7.7	2.4	$ 2.4
Restructuring charges		8.9	$ 15.9	42.8	19.6	39.9
Other	[1]			0		(0.1)
Utilized - Cash Payments				(38.3)		(32.7)
Utilized - Non-Cash				(1.5)		(1.8)
Ending Balance		10.7		10.7		7.7
Severance and termination related costs \| Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				5.1	2.4	2.4
Restructuring charges				21.9		12.1
Other	[1]			0		(0.1)
Utilized - Cash Payments				(16.9)		(9.3)
Utilized - Non-Cash				0		0
Ending Balance		10.1		10.1		5.1
Asset impairment and accelerated depreciation \| Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				0	0	0
Restructuring charges				1.5		1.8
Other	[1]			0		0
Utilized - Cash Payments				0		0
Utilized - Non-Cash				(1.5)		(1.8)
Ending Balance		0		0		0
Other related costs \| Project Fuel
Restructuring Reserve [Roll Forward]
Beginning Balance				2.6	$ 0	0
Restructuring charges				19.4		26
Other	[1]			0		0
Utilized - Cash Payments				(21.4)		(23.4)
Utilized - Non-Cash				0		0
Ending Balance		$ 0.6		$ 0.6		$ 2.6

[1]	Includes the impact of currency translation.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended			9 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2017	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Income Tax Disclosure [Abstract]
(Loss) earnings before income taxes	$ (481.7)	$ 21.4		$ (410.4)	$ 140.3
Effective tax rate	8.40%	42.90%		4.10%	40.20%
Income tax (benefit) provision	$ (40.3)	$ 9.3		$ (16.8)	$ 56.4
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax (benefit) provision	$ (40.3)	$ 9.3		$ (16.8)	56.4
Federal statutory income tax rate			35.00%	21.00%
Fiscal 2018 blended tax rate						24.50%
US Tax Act
Income Tax Disclosure [Abstract]
Income tax (benefit) provision				$ 4.7	17.4
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income tax (benefit) provision				$ 4.7	17.4
Transition tax, repatriation of foreign earnings, provision					94.2
Tax benefit, re-rate of DTAs for tax act					$ 76.8

Earnings per Share (Schedule of

Earnings per Share (Schedule of Weighted-Average Shares Outstanding) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Schedule Of Weighted Average Number Of Shares [Line Items]
Basic weighted-average shares outstanding (in shares)	54.1	54	54.1	54.5
Effect of dilutive securities (in shares)	0	0.1	0	0.1
Diluted weighted-average shares outstanding (in shares)	54.1	54.1	54.1	54.6
RSE awards
Schedule Of Weighted Average Number Of Shares [Line Items]
Effect of dilutive securities (in shares)	0	0.1	0	0.1

Earnings per Share (Narrative)

Earnings per Share (Narrative) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.5	0.5	0.5	0.5
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.2	0.1	0.2	0.1

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Jun. 30, 2019	Sep. 30, 2018
Goodwill [Line Items]
Impairment charges	$ 387
Cumulative translation adjustment	3.6
Goodwill [Roll Forward]
Goodwill, gross	1,471.6	$ 1,475.2
Beginning balance	1,450.8
Accumulated goodwill impairment loss	(411.4)	(24.4)
Ending balance	1,060.2	1,450.8
Wet Shave
Goodwill [Line Items]
Impairment charges	358
Cumulative translation adjustment	2.5
Goodwill [Roll Forward]
Goodwill, gross	965.7	968.2
Beginning balance	968.2
Accumulated goodwill impairment loss	(358)	0
Ending balance	607.7	968.2
Sun and Skin Care
Goodwill [Line Items]
Impairment charges	0
Cumulative translation adjustment	0.5
Goodwill [Roll Forward]
Goodwill, gross	228.9	229.4
Beginning balance	229.4
Accumulated goodwill impairment loss	0	0
Ending balance	228.9	229.4
Feminine Care
Goodwill [Line Items]
Impairment charges	0
Cumulative translation adjustment	0.6
Goodwill [Roll Forward]
Goodwill, gross	207.4	208
Beginning balance	208
Accumulated goodwill impairment loss	0	0
Ending balance	207.4	208
All Other
Goodwill [Line Items]
Impairment charges	29	24.4
Cumulative translation adjustment	0
Goodwill [Roll Forward]
Goodwill, gross	69.6	69.6
Beginning balance	45.2
Accumulated goodwill impairment loss	(53.4)	(24.4)
Ending balance	$ 16.2	$ 45.2
Skin Care
Goodwill [Line Items]
Reporting unit, fair value in excess of carry value	102.00%
Goodwill, weighted average cost of capital	9.60%
Valuation, long term growth rate	2.00%
Feminine Care
Goodwill [Line Items]
Reporting unit, fair value in excess of carry value	105.00%
Goodwill, weighted average cost of capital	7.90%
Valuation, long term growth rate	0.50%

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 464		$ 464		$ 465
Amortizable intangible assets, accumulated amortization	210.5		210.5		197.5
Amortizable intangible assets, net	253.5		253.5		267.5
Amortization of intangibles	4.4	$ 4.6	13.4	$ 13.2
Amortizable intangible assets, amortization expense, remainder of 2019	4.3		4.3
Amortizable intangible assets, amortization expense, fiscal 2020	17.1		17.1
Amortizable intangible assets, amortization expense, fiscal 2021	16.5		16.5
Amortizable intangible assets, amortization expense, fiscal 2022	16.3		16.3
Amortizable intangible assets, amortization expense, fiscal 2023	16.3		16.3
Amortizable intangible assets, amortization expense, fiscal 2024	16.2		16.2
Amortizable intangible assets, amortization expense, thereafter	166.8		166.8
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	206.6		206.6		206.7
Amortizable intangible assets, accumulated amortization	32.8		32.8		25.4
Amortizable intangible assets, net	173.8		173.8		181.3
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	78.8		78.8		79
Amortizable intangible assets, accumulated amortization	76.4		76.4		75.9
Amortizable intangible assets, net	2.4		2.4		3.1
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	178.6		178.6		179.3
Amortizable intangible assets, accumulated amortization	101.3		101.3		96.2
Amortizable intangible assets, net	$ 77.3		$ 77.3		$ 83.1

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2019	Sep. 30, 2018
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 667.9	$ 831.5
Indefinite-lived intangible assets, increase	(163.6)
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	180.8	182.2
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	388.4	475.6
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	29.9	29.9
All Other
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	68.8	$ 143.8
Wet Ones \| Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Impairment of intangible assets	87
Diaper Genie \| All Other
Indefinite-lived Intangible Assets [Line Items]
Impairment of intangible assets	$ 75

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Jun. 30, 2019	Sep. 30, 2018
Inventories
Raw materials and supplies	$ 52.4	$ 52
Work in process	73.4	67.5
Finished products	246.9	210
Total inventories	372.7	329.5
Other Current Assets
Miscellaneous receivables	20	12.6
Prepaid expenses	74.6	68.4
Value added tax collectible from customers	25.4	25.2
Income taxes receivable	20.1	17.3
Other	2.2	5.3
Total other current assets	142.3	128.8
Property, Plant and Equipment
Land	19	19.2
Buildings	137.6	141.9
Machinery and equipment	1,004	964.8
Capitalized software costs	47.9	48.4
Construction in progress	27.4	59.9
Total gross property, plant and equipment	1,235.9	1,234.2
Accumulated depreciation and amortization	(835.2)	(810.1)
Total property, plant and equipment, net	400.7	424.1
Other Current Liabilities
Accrued advertising, sales promotion and allowances	64.9	28.2
Accrued trade allowances	26.7	29.9
Accrued salaries, vacations and incentive compensation	50.9	44.2
Income taxes payable	18.9	20.3
Returns reserve	50.6	58.6
Restructuring reserve	10.7	7.7
Value added tax payable	8.2	4
Deferred compensation	6.9	6.3
Other	81.3	86.3
Total other current liabilities	319.1	285.5
Other Liabilities
Pensions and other retirement benefits	87.7	91.5
Deferred compensation	33.1	40.7
Other non-current liabilities	82.2	79.6
Total other liabilities	$ 203	$ 211.8

Accounts Receivable Facility (N

Accounts Receivable Facility (Narrative) (Details) - Accounts receivable sales agreement - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Transfer of Financial Assets Accounted for as Sales [Line Items]
Transfer of accounts receivable, period to date sold	$ 308.2	$ 328.5	$ 754.2	$ 820.1
Transfer of accounts receivable, sales amount derecognized	119.2		119.2		$ 77.9
Loss on sale of accounts receivable	$ 0.9	$ 0.8	$ 2.2	$ 1.8

Debt (Details)

Debt (Details) - USD ($) $ in Millions		9 Months Ended
Debt (Details) - USD ($) $ in Millions		Jun. 30, 2019	Jun. 30, 2018	Sep. 30, 2018
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 1,225		$ 1,292
Current maturities of long-term debt		125		184.9
Unamortized discount and debit issuance costs	[1],[2]	2.5		3.3
Long-term debt		1,097.5		1,103.8
Notes payable		12.6		8.2
Term Loan repayment		185	$ 0
Senior notes \| Senior notes due 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities		600		600
Unamortized debt issuance costs		0.9		1.2
Senior notes \| Senior notes due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities		500		500
Unamortized debt issuance costs		1.2		1.5
Unamortized discount		0.4		0.5
Domestic line of credit
Debt Instrument [Line Items]
Total long-term debt, including current maturities		125		7
Loans payable
Debt Instrument [Line Items]
Total long-term debt, including current maturities		$ 0		185
Current maturities of long-term debt				184.9
Unamortized debt issuance costs				$ 0.1

[1]	At June 30, 2019 and September 30, 2018, the balance for the senior notes due 2022 was reflected net of discount of $0.4 and $0.5 , respectively.
[2]	At June 30, 2019 , the balance for the senior notes due 2021 and the senior notes due 2022 are reflected net of debt issuance costs of $0.9 and $1.2 , respectively. At September 30, 2018, the balance for the senior notes due 2021, the senior notes due 2022, and the term loan are reflected net of debt issuance costs of $1.2 , $1.5 and $0.1 , respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
Retirement Plans (Details) - USD ($) $ in Millions	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Retirement Benefits [Abstract]
Service cost	$ 0.7	$ 0.7	$ 2.2	$ 2.2
Interest cost	4.7	4.3	14.1	12.9
Expected return on plan assets	(6.4)	(7.1)	(19)	(21.4)
Recognized net actuarial loss	1.1	1.1	3.1	3.4
Net periodic cost (benefit)	$ 0.1	$ (1)	$ 0.4	$ (2.9)

Shareholders' Equity (Details)

Shareholders' Equity (Details) shares in Millions	Jun. 30, 2019shares
Stockholders' Equity Note [Abstract]
Shares authorized for repurchase (in shares)	10

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		9 Months Ended
		Jun. 30, 2019	Jun. 30, 2018
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (148.3)	$ (131.4)
OCI before reclassifications	[1]	(11.8)	(9)
Reclassifications to earnings		(0.8)	4.1
Ending balance		(160.9)	(136.3)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(40.6)	(29)
OCI before reclassifications	[1]	(9.4)	(10.4)
Reclassifications to earnings		0	0
Ending balance		(50)	(39.4)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(110.3)	(101.3)
OCI before reclassifications	[1]	(2.5)	0.2
Reclassifications to earnings		2.3	2.4
Ending balance		(110.5)	(98.7)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		2.6	(1.1)
OCI before reclassifications	[1]	0.1	1.2
Reclassifications to earnings		(3.1)	1.7
Ending balance		$ (0.4)	$ 1.8

[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings				$ 0.8	$ (4.1)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ 1.4	$ (1)	4.5	(2.5)
Gains and losses on cash flow hedges, foreign exchange contracts, tax		0.4	(0.4)	1.4	(0.8)
Gains and losses on cash flow hedges, foreign exchange contracts, after tax		1	(0.6)	3.1	(1.7)
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	[1]	(1.1)	(1.1)	(3.1)	(3.4)
Amortization of defined benefit pension and postretirement items, before tax		(1.1)	(1.1)	(3.1)	(3.4)
Amortization of defined benefit pension and postretirement items, tax		(0.3)	(0.3)	(0.8)	(1)
Amortization of defined benefit pension and postretirement items, after tax		(0.8)	(0.8)	(2.3)	(2.4)
Reclassifications to earnings		0.2	(1.4)	0.8	(4.1)
Other (income) expense, net \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ 1.4	$ (1)	$ 4.5	$ (2.5)

[1]	These AOCI components are included in the computation of net periodic cost (benefit). See Note 11 of Notes to Condensed Consolidated Financial Statements

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2019USD ($)contracts	Jun. 30, 2018USD ($)	Jun. 30, 2019USD ($)contracts	Jun. 30, 2018USD ($)	Sep. 30, 2018USD ($)
Derivative [Line Items]
Long-term debt		$ 1,225		$ 1,225		$ 1,292
Current maturities of long-term debt		125		125		184.9
Fixed rate
Derivative [Line Items]
Long-term debt		1,100		1,100
Fair value of long-term debt		1,066.7		1,066.7		1,061.2
Loans payable
Derivative [Line Items]
Long-term debt		$ 0		$ 0		185
Fair value of long-term debt						185
Current maturities of long-term debt						184.9
Not designated as hedge \| FX contract
Derivative [Line Items]
Open foreign currency contracts \| contracts		6		6
Notional value		$ 56.1		$ 56.1
Cash flow hedge \| Designated as hedge \| FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ (0.5)		$ (0.5)		$ 3.9
Open foreign currency contracts \| contracts		61		61
Notional value		$ 126.9		$ 126.9
Other (income) expense, net \| Not designated as hedge \| FX contract
Derivative [Line Items]
Gain (loss) recognized in income	[1]	$ (1.1)	$ 3	$ (1.7)	$ 0.2

[1]	Gain (loss) was recorded in Other expense, net.

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Schedule of Fair Values of Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2019	Sep. 30, 2018
Not designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ (0.9)	$ 1.3
Cash flow hedge \| Designated as hedge
Derivatives, Fair Value [Line Items]
Estimated fair value of derivatives	[1]	$ (0.5)	$ 3.9

[1]	All derivative assets are presented in Other current assets or Other assets. All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_5

Financial Instruments and Risk Management (Schedule of Gains and Losses on Derivative Instruments) (Details) - FX contract - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Designated as hedge \| Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in OCI	[1]	$ (1.5)	$ 5.4	$ 0.1	$ 1.7
Other (income) expense, net \| Designated as hedge \| Cash flow hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) reclassified from AOCI into income (effective portion)	[1],[2]	1.4	(1)	4.5	(2.5)
Other (income) expense, net \| Not designated as hedge
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	[2]	$ 1.1	$ (3)	$ 1.7	$ (0.2)

[1]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and were deemed highly effective in offsetting associated risk.
[2]	Gain (loss) was recorded in Other expense, net.

Financial Instruments and Ris_6

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions		Jun. 30, 2019	Sep. 30, 2018
Derivative [Line Items]
Gross amounts of recognized assets	[1]	$ 0.7	$ 5.3
Gross amounts of recognized liabilities	[2]	(2.3)	0
Gross amounts offset in the balance sheet	[1]	0	(0.1)
Gross amounts offset in the balance sheet	[2]	0.2	0
Net amounts of assets presented in the balance sheet	[1]	0.7	5.2
Net amounts of liabilities presented in the balance sheet	[2]	$ (2.1)	$ 0

[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.

Financial Instruments and Ris_7

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Jun. 30, 2019	Sep. 30, 2018
Derivative [Line Items]
Deferred compensation	$ (39.8)	$ (46.9)
Net liabilities at estimated fair value	(41.2)	(41.7)
FX contract
Derivative [Line Items]
Derivatives - foreign currency contracts	$ (1.4)	$ 5.2

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Segment Reporting Information [Line Items]
Net sales		$ 609.2	$ 620.6	$ 1,613	$ 1,697
Impairment charges		549	24.4	549	24.4
Restructuring and related costs	[1]	(8.9)	(15.9)	(42.8)	(19.6)
Gain on sale of of Playtex gloves		0	0.6	0	(15.3)
Amortization of intangibles		(4.4)	(4.6)	(13.4)	(13.2)
Interest and other expense, net		(18.3)	(18.4)	(49.3)	(53.7)
Earnings before income taxes		(481.7)	21.4	(410.4)	140.3
Wet Shave
Segment Reporting Information [Line Items]
Net sales		327.7	341.1	909.8	980.4
Segment profit		54.1	55	164.8	177.6
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales		168.4	162.8	380.3	374.2
Segment profit		42.2	33.9	82.1	76.3
Feminine Care
Segment Reporting Information [Line Items]
Net sales		80.9	84.1	230.2	247
Segment profit		15.5	11	36.7	25.7
All Other
Segment Reporting Information [Line Items]
Net sales		32.2	32.6	92.7	95.4
Segment profit		3.6	5.4	10.8	16.8
Operating Segments
Segment Reporting Information [Line Items]
Segment profit		115.4	105.3	294.4	296.4
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses		(13.1)	(17.7)	(43.5)	(55.6)
Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Feminine and Infant Care evaluation costs	[2]	(0.5)	0	(1.5)	0
Investor settlement expense	[3]	0	0	(0.9)	0
Cost of products sold
Segment Reporting Information [Line Items]
Sun Care reformulation costs	[4]	(1)	0	(1.5)	0
IT enablement \| Project Fuel \| Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Restructuring and related costs		(1.8)	(0.5)	(5.1)	(0.5)
Harry's
Segment Reporting Information [Line Items]
Acquisition and integration costs	[5]	(1.8)	0	(1.8)	0
Harry's \| Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Acquisition and integration costs		(1.8)		(1.8)
Jack Black
Segment Reporting Information [Line Items]
Acquisition and integration costs	[6]	(0.1)	(2.3)	(1.1)	(4.9)
Jack Black \| Selling, general and administrative expenses
Segment Reporting Information [Line Items]
Acquisition and integration costs		$ (0.1)	(0.5)	$ (1.1)	(3.1)
Jack Black \| Cost of products sold
Segment Reporting Information [Line Items]
Acquisition and integration costs			$ (1.8)		$ (1.8)

[1]	Restructuring costs associated with Project Fuel, an enterprise-wide transformational initiative that is designed to address all aspects of our business and cost structure, simplifying and transforming the organization, structure and key processes that will enable us to achieve our desired future state operations. Includes pre-tax SG&A of $1.8 and $5.1 for the three and nine months ended June 30, 2019, respectively, and $0.5 for the three and nine months ended June 30, 2018 associated with certain information technology enablement expenses for Project Fuel.
[2]	Includes pre-tax SG&A of $0.5 and $1.5 for the three and nine months ended June 30, 2019, respectively, associated with consulting costs for the Company to evaluate segments.
[3]	Includes pre-tax SG&A of $0.9 for the nine months ended June 30, 2019, associated with a settlement with an investor.
[4]	Includes pre-tax Cost of products sold of $1.0 and $1.5 for the three and nine months ended June 30, 2019, respectively, associated with supply chain changes on select Sun Care products.
[5]	Acquisition and integration costs related to Harry’s totaling $1.8 for the three and nine months ended June 30, 2019, were included in SG&A on the Consolidated Statement of Earnings.
[6]	Acquisition and integration costs related to Jack Black totaling $0.1 and $1.1 for the three and nine months ended June 30, 2019, respectively, were included in SG&A on the Consolidated Statement of Earnings. Acquisition and integration costs related to Jack Black totaling $0.5 and $3.1 for the three and nine months ending June 30, 2018, respectively, were included in SG&A in the Consolidated Statement of Earnings. Additionally, acquisition and integration costs of $1.8 were included in Cost of products sold for the three and nine months ended June 30, 2018.

Segment Data Segment Data (Sche

Segment Data Segment Data (Schedule of Sales by Geographical Area) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue from External Customer [Line Items]
Net sales	$ 609.2	$ 620.6	$ 1,613	$ 1,697
United States
Revenue from External Customer [Line Items]
Net sales	362.1	368.8	923.7	967.3
International
Revenue from External Customer [Line Items]
Net sales	$ 247.1	$ 251.8	$ 689.3	$ 729.7

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenue from External Customer [Line Items]
Net sales	$ 609.2	$ 620.6	$ 1,613	$ 1,697
Razors and blades
Revenue from External Customer [Line Items]
Net sales	291.3	304.6	807.2	877.5
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	80.9	84.1	230.2	247
Skin care products
Revenue from External Customer [Line Items]
Net sales	32.7	30.7	95.1	76.7
Sun care products
Revenue from External Customer [Line Items]
Net sales	135.7	132.1	285.2	297.5
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	36.4	36.5	102.6	102.9
Infant care and other
Revenue from External Customer [Line Items]
Net sales	$ 32.2	$ 32.6	$ 92.7	$ 95.4

Guarantor and Non-Guarantor F_3

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Income Statement [Abstract]
Net sales	$ 609.2	$ 620.6	$ 1,613	$ 1,697
Cost of products sold	317	318.9	876.4	894.9
Gross profit	292.2	301.7	736.6	802.1
Selling, general and administrative expense	94.8	101.3	280.2	303.5
Advertising and sales promotion expense	91.8	105.3	191.3	229.9
Research and development expense	12.9	14.9	39.5	46.5
Impairment charges	549	24.4	549	24.4
Restructuring charges	(7.1)	(15.4)	(37.7)	(19.1)
Gain on sale of of Playtex gloves	0	0.6	0	(15.3)
Interest expense associated with debt	15.6	16.5	48	52.5
Other expense, net	2.7	1.9	1.3	1.2
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	0	0	0	0
(Loss) earnings before income taxes	(481.7)	21.4	(410.4)	140.3
Income tax (benefit) provision	(40.3)	9.3	(16.8)	56.4
Net (loss) earnings	(441.4)	12.1	(393.6)	83.9
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net (loss) earnings	(441.4)	12.1	(393.6)	83.9
Other comprehensive income (loss), net of tax	10.1	(30)	(12.6)	(4.9)
Total comprehensive income (loss)	(431.3)	(17.9)	(406.2)	79
Eliminations
Income Statement [Abstract]
Net sales	(88.2)	(82.5)	(252.5)	(235.4)
Cost of products sold	(88.2)	(82.5)	(252.5)	(235.4)
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0	0	0
Advertising and sales promotion expense	0	0	0	0
Research and development expense	0	0	0	0
Impairment charges	0	0	0	0
Restructuring charges	0	0	0	0
Gain on sale of of Playtex gloves		0		0
Interest expense associated with debt	0	0	0	0
Other expense, net	0	0	0	0
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	(523.5)	47.6	(411.9)	192.3
(Loss) earnings before income taxes	523.5	(47.6)	411.9	(192.3)
Income tax (benefit) provision	0	0	0	0
Net (loss) earnings	523.5	(47.6)	411.9	(192.3)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net (loss) earnings	523.5	(47.6)	411.9	(192.3)
Other comprehensive income (loss), net of tax	(20.7)	60.5	23.8	11.4
Total comprehensive income (loss)	502.8	12.9	435.7	(180.9)
Parent
Income Statement [Abstract]
Net sales	0	0	0	0
Cost of products sold	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0	0	0
Advertising and sales promotion expense	0	0	0	0
Research and development expense	0	0	0	0
Impairment charges	0	0	0	0
Restructuring charges	0	0	0	0
Gain on sale of of Playtex gloves		0		0
Interest expense associated with debt	13.3	13.4	40.1	40.1
Other expense, net	0	0	0	0
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	431.4	(21.9)	363.3	(113.2)
(Loss) earnings before income taxes	(444.7)	8.5	(403.4)	73.1
Income tax (benefit) provision	(3.3)	(3.6)	(9.8)	(10.8)
Net (loss) earnings	(441.4)	12.1	(393.6)	83.9
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net (loss) earnings	(441.4)	12.1	(393.6)	83.9
Other comprehensive income (loss), net of tax	10.1	(30)	(12.6)	(4.9)
Total comprehensive income (loss)	(431.3)	(17.9)	(406.2)	79
Guarantors
Income Statement [Abstract]
Net sales	420.9	425.1	1,090.6	1,143.9
Cost of products sold	237	237.5	651.2	663.7
Gross profit	183.9	187.6	439.4	480.2
Selling, general and administrative expense	58.1	61.6	171.5	189
Advertising and sales promotion expense	58.3	70	110.8	139.3
Research and development expense	12.9	14.9	39.5	46.5
Impairment charges	437.3	24.4	437.3	24.4
Restructuring charges	(4.8)	(13.4)	(24.5)	(15.8)
Gain on sale of of Playtex gloves		0.6		(15.3)
Interest expense associated with debt	2.1	2.8	7.3	11.6
Other expense, net	0.6	(0.2)	1.6	(1.1)
Intercompany service fees	(3.1)	(3.5)	(12.5)	(14.6)
Equity in earnings of subsidiaries	92.1	(25.7)	48.6	(79.1)
(Loss) earnings before income taxes	(479.2)	29.3	(389.2)	163.7
Income tax (benefit) provision	(47.8)	7.4	(25.9)	50.5
Net (loss) earnings	(431.4)	21.9	(363.3)	113.2
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net (loss) earnings	(431.4)	21.9	(363.3)	113.2
Other comprehensive income (loss), net of tax	10.1	(30)	(12.6)	(4.9)
Total comprehensive income (loss)	(421.3)	(8.1)	(375.9)	108.3
Non-Guarantors
Income Statement [Abstract]
Net sales	276.5	278	774.9	788.5
Cost of products sold	168.2	163.9	477.7	466.6
Gross profit	108.3	114.1	297.2	321.9
Selling, general and administrative expense	36.7	39.7	108.7	114.5
Advertising and sales promotion expense	33.5	35.3	80.5	90.6
Research and development expense	0	0	0	0
Impairment charges	111.7	0	111.7	0
Restructuring charges	(2.3)	(2)	(13.2)	(3.3)
Gain on sale of of Playtex gloves		0		0
Interest expense associated with debt	0.2	0.3	0.6	0.8
Other expense, net	2.1	2.1	(0.3)	2.3
Intercompany service fees	3.1	3.5	12.5	14.6
Equity in earnings of subsidiaries	0	0	0	0
(Loss) earnings before income taxes	(81.3)	31.2	(29.7)	95.8
Income tax (benefit) provision	10.8	5.5	18.9	16.7
Net (loss) earnings	(92.1)	25.7	(48.6)	79.1
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net (loss) earnings	(92.1)	25.7	(48.6)	79.1
Other comprehensive income (loss), net of tax	10.6	(30.5)	(11.2)	(6.5)
Total comprehensive income (loss)	$ (81.5)	$ (4.8)	$ (59.8)	$ 72.6

Guarantor and Non-Guarantor F_4

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Jun. 30, 2019		Mar. 31, 2019	Sep. 30, 2018		Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017
Current assets
Cash and cash equivalents	$ 279			$ 266.4		$ 218.5		$ 502.9
Trade receivables, net	241.6			226.5
Inventories	372.7			329.5
Other current assets	142.3			128.8
Total current assets	1,035.6			951.2
Investment in subsidiaries	0			0
Intercompany receivables, net	0	[1]		0	[2]
Property, plant and equipment, net	400.7			424.1
Goodwill	1,060.2			1,450.8
Other intangible assets, net	921.4			1,099
Other assets	34.4			28.2
Total assets	3,452.3			3,953.3
Liabilities [Abstract]
Current liabilities	678.6			717
Intercompany payables, net	0	[1]		0	[2]
Long-term debt	1,097.5			1,103.8
Deferred income tax liabilities	118.7			176.1
Other liabilities	203			211.8
Total liabilities	2,097.8			2,208.7
Shareholders’ equity
Total shareholders' equity	1,354.5		$ 1,782.1	1,744.6		1,717.9	$ 1,731.3	1,741.7
Total liabilities and shareholders' equity	3,452.3			3,953.3
Eliminations
Current assets
Cash and cash equivalents	0			0		0		0
Trade receivables, net	0			0
Inventories	0			0
Other current assets	0			0
Total current assets	0			0
Investment in subsidiaries	(4,514.9)			(4,987.4)
Intercompany receivables, net	(929.8)	[1]		(900)	[2]
Property, plant and equipment, net	0			0
Goodwill	0			0
Other intangible assets, net	0			0
Other assets	0			0
Total assets	(5,444.7)			(5,887.4)
Liabilities [Abstract]
Current liabilities	0			0
Intercompany payables, net	(929.8)	[1]		(900)	[2]
Long-term debt	0			0
Deferred income tax liabilities	0			0
Other liabilities	0			0
Total liabilities	(929.8)			(900)
Shareholders’ equity
Total shareholders' equity	(4,514.9)			(4,987.4)
Total liabilities and shareholders' equity	(5,444.7)			(5,887.4)
Parent
Current assets
Cash and cash equivalents	0			0		0		0
Trade receivables, net	0			0
Inventories	0			0
Other current assets	0			0
Total current assets	0			0
Investment in subsidiaries	3,387.8			3,760
Intercompany receivables, net	0	[1]		0	[2]
Property, plant and equipment, net	0			0
Goodwill	0			0
Other intangible assets, net	0			0
Other assets	0.8			1
Total assets	3,388.6			3,761
Liabilities [Abstract]
Current liabilities	6.8			19.7
Intercompany payables, net	929.8	[1]		900	[2]
Long-term debt	1,097.5			1,096.7
Deferred income tax liabilities	0			0
Other liabilities	0			0
Total liabilities	2,034.1			2,016.4
Shareholders’ equity
Total shareholders' equity	1,354.5			1,744.6
Total liabilities and shareholders' equity	3,388.6			3,761
Guarantors
Current assets
Cash and cash equivalents	1.6			2.5		5.6		6.4
Trade receivables, net	60.4			46.1
Inventories	201			175.4
Other current assets	47.1			48.8
Total current assets	310.1			272.8
Investment in subsidiaries	1,127.1			1,227.4
Intercompany receivables, net	907.9	[1]		836.1	[2]
Property, plant and equipment, net	295.7			316.7
Goodwill	762.1			1,037.5
Other intangible assets, net	714.8			886.5
Other assets	(0.1)			0.1
Total assets	4,117.6			4,577.1
Liabilities [Abstract]
Current liabilities	445.1			471.8
Intercompany payables, net	0	[1]		0	[2]
Long-term debt	0			7.1
Deferred income tax liabilities	98.3			142.6
Other liabilities	186.4			195.6
Total liabilities	729.8			817.1
Shareholders’ equity
Total shareholders' equity	3,387.8			3,760
Total liabilities and shareholders' equity	4,117.6			4,577.1
Non-Guarantors
Current assets
Cash and cash equivalents	277.4			263.9		$ 212.9		$ 496.5
Trade receivables, net	181.2			180.4
Inventories	171.7			154.1
Other current assets	95.2			80
Total current assets	725.5			678.4
Investment in subsidiaries	0			0
Intercompany receivables, net	21.9	[1]		63.9	[2]
Property, plant and equipment, net	105			107.4
Goodwill	298.1			413.3
Other intangible assets, net	206.6			212.5
Other assets	33.7			27.1
Total assets	1,390.8			1,502.6
Liabilities [Abstract]
Current liabilities	226.7			225.5
Intercompany payables, net	0	[1]		0	[2]
Long-term debt	0			0
Deferred income tax liabilities	20.4			33.5
Other liabilities	16.6			16.2
Total liabilities	263.7			275.2
Shareholders’ equity
Total shareholders' equity	1,127.1			1,227.4
Total liabilities and shareholders' equity	$ 1,390.8			$ 1,502.6

[1]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business.
[2]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity, and other intercompany activities in the normal course of business.

Guarantor and Non-Guarantor F_5

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	9 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash Flow from Operating Activities
Net cash flow from (used by) operations	$ 98.2	$ 181.5
Cash Flow from Investing Activities
Capital expenditures	(38.7)	(41.8)
Acquisitions, net of cash acquired	0	90.2
Collection of deferred purchase price from accounts receivable sold	9	7.2
Playtex gloves sale	0	19
Proceeds from sale of assets	4.1	4.7
Payments Intercompany receivable and payable, net	0
Payments for equity contributions	0
Payments for other investing activities	1.3	0
Net cash (used by) from investing activities	(26.9)	(101.1)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	316	477
Cash payments on debt with original maturities greater than 90 days	(198)	(722)
Term Loan repayment	185	0
Net increase in debt with original maturities of 90 days or less	5.7	0.2
Common shares purchased	0	(124.4)
Intercompany dividend	0	0
Net financing inflow from the Accounts Receivable Facility	5.6	4.6
Proceeds for Intercompany receivable and payable, net	0
Proceeds from Contributions from Parent	0
Employee shares withheld for taxes	(1.8)	(2.2)
Net cash from (used by) financing activities	(57.5)	(366.8)
Effect of exchange rate changes on cash	(1.2)	2
Net decrease in cash and cash equivalents	12.6	(284.4)
Cash and cash equivalents, beginning of period	266.4	502.9
Cash and cash equivalents, end of period	279	218.5
Eliminations
Cash Flow from Operating Activities
Net cash flow from (used by) operations	(45)	(350.2)
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired		0
Collection of deferred purchase price from accounts receivable sold	0	0
Playtex gloves sale		0
Proceeds from sale of assets	0	0
Payments Intercompany receivable and payable, net	29.8
Payments for equity contributions	1
Payments for other investing activities	0
Net cash (used by) from investing activities	30.8	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Term Loan repayment	0
Net increase in debt with original maturities of 90 days or less	0	0
Common shares purchased		0
Intercompany dividend	45	350.2
Net financing inflow from the Accounts Receivable Facility	0	0
Proceeds for Intercompany receivable and payable, net	(29.8)
Proceeds from Contributions from Parent	(1)
Employee shares withheld for taxes	0	0
Net cash from (used by) financing activities	14.2	350.2
Effect of exchange rate changes on cash	0	0
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Parent
Cash Flow from Operating Activities
Net cash flow from (used by) operations	(27)	126.6
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired		0
Collection of deferred purchase price from accounts receivable sold	0	0
Playtex gloves sale		0
Proceeds from sale of assets	0	0
Payments Intercompany receivable and payable, net	0
Payments for equity contributions	(1)
Payments for other investing activities	0
Net cash (used by) from investing activities	(1)	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Term Loan repayment	0
Net increase in debt with original maturities of 90 days or less	0	0
Common shares purchased		(124.4)
Intercompany dividend	0	0
Net financing inflow from the Accounts Receivable Facility	0	0
Proceeds for Intercompany receivable and payable, net	29.8
Proceeds from Contributions from Parent	0
Employee shares withheld for taxes	(1.8)	(2.2)
Net cash from (used by) financing activities	28	(126.6)
Effect of exchange rate changes on cash	0	0
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	99.8	331.4
Cash Flow from Investing Activities
Capital expenditures	(22.7)	(31.3)
Acquisitions, net of cash acquired		90.2
Collection of deferred purchase price from accounts receivable sold	9	7.2
Playtex gloves sale		19
Proceeds from sale of assets	4	4.7
Payments Intercompany receivable and payable, net	(29.8)
Payments for equity contributions	0
Payments for other investing activities	1.3
Net cash (used by) from investing activities	(40.8)	(90.6)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	316	477
Cash payments on debt with original maturities greater than 90 days	(198)	(722)
Term Loan repayment	185
Net increase in debt with original maturities of 90 days or less	1.5	(1.2)
Common shares purchased		0
Intercompany dividend	0	0
Net financing inflow from the Accounts Receivable Facility	5.6	4.6
Proceeds for Intercompany receivable and payable, net	0
Proceeds from Contributions from Parent	0
Employee shares withheld for taxes	0	0
Net cash from (used by) financing activities	(59.9)	(241.6)
Effect of exchange rate changes on cash	0	0
Net decrease in cash and cash equivalents	(0.9)	(0.8)
Cash and cash equivalents, beginning of period	2.5	6.4
Cash and cash equivalents, end of period	1.6	5.6
Non-Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	70.4	73.7
Cash Flow from Investing Activities
Capital expenditures	(16)	(10.5)
Acquisitions, net of cash acquired		0
Collection of deferred purchase price from accounts receivable sold	0	0
Playtex gloves sale		0
Proceeds from sale of assets	0.1	0
Payments Intercompany receivable and payable, net	0
Payments for equity contributions	0
Payments for other investing activities	0
Net cash (used by) from investing activities	(15.9)	(10.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Term Loan repayment	0
Net increase in debt with original maturities of 90 days or less	4.2	1.4
Common shares purchased		0
Intercompany dividend	(45)	(350.2)
Net financing inflow from the Accounts Receivable Facility	0	0
Proceeds for Intercompany receivable and payable, net	0
Proceeds from Contributions from Parent	1
Employee shares withheld for taxes	0	0
Net cash from (used by) financing activities	(39.8)	(348.8)
Effect of exchange rate changes on cash	(1.2)	2
Net decrease in cash and cash equivalents	13.5	(283.6)
Cash and cash equivalents, beginning of period	263.9	496.5
Cash and cash equivalents, end of period	$ 277.4	$ 212.9